PROSPECTUS                                                  Rule 424(b)(2)
                    3,030,000 Shares of Class A Common Stock

                                     [LOGO]
                            -------------------------

        This  Prospectus  relates  to up to  3,030,000  shares of Class A Common
Stock,  par value $.001 per share (the "Class A Common Stock"),  of Nu Skin Asia
Pacific, Inc. ("Nu Skin Asia Pacific" or the "Company"),  including the offering
by the Company of up to  1,605,000  shares of Class A Common  Stock to be issued
upon the exercise of options held by distributors (the "Distributor Options") of
Nu Skin International,  Inc. ("NSI"), an affiliate of the Company,  the offering
by the Company to its employees of up to 175,000  shares of Class A Common Stock
as employee stock bonus awards and the offering by NSI and its affiliates (other
than the  Company)  (the "Rule 415  Selling  Stockholders")  of up to  1,250,000
shares  of Class A Common  Stock to their  employees  as  employee  stock  bonus
awards.  The  offering  of the  shares of Class A Common  Stock  underlying  the
Distributor  Options  and the  employee  stock  bonus  awards  are  collectively
referred to as the "Rule 415 Offerings." See "Rule 415 Selling Stockholders" and
"Plan of Distribution."

        The Class A Common  Stock may be offered  from time to time  directly by
the holders or pledgees,  donees,  transferees or other  successors in interest.
Alternatively,  the Class A Common Stock may be offered from time to time by the
holders or  through  brokers  or  dealers  who may act solely as agents,  or may
acquire shares as principals.  The  distribution of the Class A Common Stock may
be  effected  in one or more  transactions  that may take  place on the New York
Stock  Exchange,   including  block  trades,   ordinary  brokers'  transactions,
privately negotiated transactions or through sales to one or more broker/dealers
for resale of such securities as principals,  at market prices prevailing at the
time  of  sale,  at  prices  related  to such  prevailing  market  prices  or at
negotiated prices. Usual and customary or specifically negotiated brokerage fees
or commissions  may be paid by these holders in connection  with such sales.  In
connection with such sales, the holders and any participating brokers or dealers
may be deemed  "underwriters"  as such term is defined in the  Securities Act of
1933, as amended (the "Securities Act"). See "Plan of Distribution."

        Other  than the  exercise  price of such  Distributor  Options as may be
exercised,  the Company will not receive any of the  proceeds  from the Rule 415
Offerings.  The gross  proceeds  from the  issuance  of shares of Class A Common
Stock by the Company in connection with the exercise of the Distributor  Options
are  estimated to be  approximately  $9.2 million  (assuming the exercise of all
1,605,000 Distributor Options).

        The Class A Common Stock is traded on the New York Stock  Exchange under
the symbol "NUS." On March 11, 1998, the last reported sale price of the Class A
Common Stock was $ 24.56 per share.

        See "Risk  Factors"  beginning  on page 8 for a  discussion  of  certain
factors which should be considered by  prospective  purchasers of the securities
offered hereby.


    THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
       AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION, NOR HAS
         THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES
             COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS
               PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
                                CRIMINAL OFFENSE.








                 The date of this Prospectus is March 20, 1998.






                              AVAILABLE INFORMATION

        The Company has filed with the Securities and Exchange  Commission  (the
"Commission") a Registration Statement on Form S-3 (together with all amendments
and exhibits thereto, the "Registration Statement"), of which this Prospectus is
a part,  under the  Securities  Act with respect to the shares of Class A Common
Stock offered  hereby.  This Prospectus does not contain all the information set
forth in the  Registration  Statement  and the exhibits and  schedules  thereto,
certain  portions  of which  have been  omitted  as  permitted  by the rules and
regulations  of the  Commission.  For further  information  with  respect to the
Company and the securities offered hereby, reference is made to the Registration
Statement, including the financial schedules and exhibits filed therewith, which
may be  examined  without  charge  at, or copies of which may be  obtained  upon
payment of prescribed fees from, the Commission and its regional  offices listed
below.  Statements  made in this  Prospectus as to the contents of any contract,
agreement  or  other  documents  are  not  necessarily  complete,  and,  in each
instance,  reference is made to the copy of such document filed as an exhibit to
the Registration Statement or otherwise with the Commission. Each such statement
shall be deemed qualified in its entirety by such reference.

        The  Company  is  subject  to  the  informational  requirements  of  the
Securities  Exchange  Act of 1934,  as  amended  (the  "Exchange  Act"),  and in
accordance therewith files reports,  proxy statements and other information with
the Commission.  The Registration Statement and the exhibits thereto, as well as
any such reports,  proxy statements and other  information  filed by the Company
with the  Commission,  may be  inspected  and  copied  at the  public  reference
facilities  maintained by the Commission at Room 1024,  450 Fifth Street,  N.W.,
Washington,  D.C. 20549,  and at the  Commission's  regional  offices at 7 World
Trade Center,  Suite 1300, New York, New York 10048 and 500 West Madison Street,
Suite 1400, Chicago,  Illinois  60661-2311.  Copies of such material also may be
obtained at prescribed rates from the Public Reference Section of the Commission
at 450 Fifth Street, N.W., Washington, D.C. 20549. The Commission also maintains
a web site at http:\\www.sec.gov  which contains reports,  proxy and information
statements and other information regarding issuers that file electronically with
the Commission.  Such reports and other information may also be inspected at the
offices of the New York Stock  Exchange,  20 Broad  Street,  New York,  New York
10005.

                           INCORPORATION BY REFERENCE

        The  following  documents  have been filed with the  Commission  and are
incorporated by reference in this Prospectus:

        (1)    The  Company's  Annual  Report  on Form  10-K for the year  ended
               December 31, 1997, as amended by the Company's  Form 10-K/A filed
               on March 19, 1998; and

        (2)    The  description  of  the  Company's  Class  A  Common  Stock  as
               contained  in the  Company's  Registration  Statement on Form 8-A
               dated November 6, 1996.

        All  documents  and  reports  filed by the  Company  pursuant to Section
13(a), 13(c), 14 or 15(d) of the Exchange Act after the date hereof and prior to
the  termination of the offering shall be deemed to be incorporated by reference
into this  Prospectus  and to be a part  hereof  from the date of filing of such
documents.  Any statement  contained in a document  incorporated or deemed to be
incorporated  by reference  herein shall be deemed to be modified or  superseded
for purposes of this Prospectus to the extent that a statement  contained herein
or in any  subsequently  filed  document which is deemed to be  incorporated  by
reference  herein  modifies or  supersedes  such  statement.  Any  statement  so
modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this Prospectus.







        The Company will furnish without  charge,  upon written or oral request,
to each person,  including  any  beneficial  owner,  to whom this  Prospectus is
delivered,  a copy  of any or all of the  documents  incorporated  by  reference
herein  other  than  exhibits  to  such  documents  (unless  such  exhibits  are
specifically  incorporated  by  reference  into such  documents).  Requests  for
documents  should be directed to Nu Skin Asia  Pacific,  Inc.,  75 West  Center,
Provo, UT 84601, Attention: Investor Relations, telephone number (801) 345-6100.

                           FORWARD-LOOKING STATEMENTS

        Certain statements made herein are  "forward-looking  statements" within
the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform
Act"). In addition,  when used in this Prospectus and the documents incorporated
herein by  reference,  the words or phrases  "will  likely  result,"  "expects,"
"intends,"  "will  continue,"  "is  anticipated,"  "estimates,"  "projects"  and
similar expressions are intended to identify "forward-looking statements" within
the  meaning of the Reform Act.  Forward-looking  statements  include  plans and
objectives of management for future  operations,  including plans and objectives
relating to the  products  and the future  economic  performance  and  financial
results of the Company. The forward-looking  statements and associated risks set
forth  or  incorporated  by  reference   herein  relate  to  the:  (i)  proposed
acquisition  of  NSI  and  certain  of its  affiliates;  (ii)  expansion  of the
Company's market share in its current markets; (iii) Company's entrance into new
markets;  (iv)  development  of new products and new product  lines  tailored to
appeal to the particular needs of consumers in specific markets; (v) stimulation
of product  sales by  introducing  new  products;  (vi)  opening of new offices,
walk-in distribution centers and distributor support centers in certain markets;
(vii) promotion of distributor  growth,  retention and leadership  through local
initiatives;  (viii)  upgrading  of the  Company's  technological  resources  to
support  distributors;  (ix)  obtaining  of  regulatory  approvals  for  certain
products,  including  LifePak;  (x) stimulation of product purchases by inactive
distributors  through  direct mail  campaigns;  (xi)  retention of the Company's
earnings for use in the operation and expansion of the Company's business; (xii)
development of brand  awareness and loyalty;  (xiii)  enhancing of the Company's
Global  Compensation  Plan  (as  defined  herein);  (xiv)  diversifying  of  the
Company's  revenue  base and  markets,  (xv)  seeking  of cost  reductions  from
vendors;  and (xvi)  establishment of local  manufacturing.  All forward-looking
statements  involve  predictions  and are subject to known and unknown risks and
uncertainties,  including, without limitation, those discussed under the caption
"Risk Factors" as well as general economic and business  conditions,  that could
cause actual results to differ  materially  from  historical  earnings and those
presently  anticipated or projected.  Readers should not place undue reliance on
any such forward-looking  statements,  which speak only as of the date made. The
factors  listed under the caption  "Risk  Factors"  could  affect the  Company's
financial  performance  and could cause the Company's  actual results for future
periods to differ  materially  from any opinions or  statements  expressed  with
respect to future  periods in any  current  statements.  Factors  and risks that
might  cause such  differences  include,  but are not  limited  to, (a)  factors
related to the Company's  reliance  upon  independent  distributors  of NSI, (b)
fluctuations in foreign currency values relative to the U.S. dollar, (c) adverse
economic and business  conditions in the  Company's  markets,  especially  South
Korea and Thailand, (d) the possibility that the proposed acquisition of NSI and
certain of its affiliates may not be consummated,  (e) the potential  effects of
adverse publicity,  including adverse publicity  regarding the Company and other
direct selling companies in South Korea and the Company's other markets, (f) the
potential  negative  impact of  distributor  actions,  (g) seasonal and cyclical
trends, (h) variations in operating results, (i) government regulation of direct
selling  activities in the PRC (as defined herein),  Malaysia and other existing
and future  markets,  (j) government  regulation of products and marketing,  (k)
import  restrictions,  (l) other regulatory issues,  including regulatory action
against  the Company or its  distributors  in any of the  Company's  markets and
particularly in South Korea, (m) the Company's reliance on certain distributors,
(n) the potential  divergence of interests between distributors and the Company,
(o) management of the Company's growth, (p) the effects on operations of the NSI
distributor  equity program,  (q) the  introduction of the Scion product line in
the Philippines and Aloe-MX in Japan,  (r) market  acceptance in South Korea and
other markets of LifePak,  the Company's core IDN product, (s) the acceptance of
new distributor walk-in centers in Japan, Thailand and Taiwan, (t) acceptance of
modifications to the Company's sales  compensation plan in the Philippines,  (u)
the Company's






ability to renegotiate or adjust vendor relationships, (v) the Company's ability
to  establish  local  manufacturing  capability,   (w)  risks  inherent  in  the
importation,  regulation and sale of personal care and  nutritional  products in
the Company's  markets,  (x) the  Company's  ability to  successfully  enter new
markets  such as Poland and Brazil and  introduce  new  products  in addition to
those already  referenced  above, (y) the Company's ability to manage growth and
deal with the possible adverse effect on the Company of the change in the status
of Hong Kong,  (z) the potential  conflicts of interest  between the Company and
NSI,  (aa)  control of the  Company by the  Original  Stockholders  (as  defined
herein),  (bb) the  anti-takeover  effects of dual classes of common stock, (cc)
the Company's reliance on and the concentration of outside  manufacturers,  (dd)
the Company's reliance on the operations of and dividends and distributions from
the Subsidiaries,  (ee) taxation and transfer pricing issues, (ff) the potential
increase in distributor  compensation expense, (gg) product liability issues and
(hh) competition in the Company's  existing and future markets.  In light of the
significant uncertainties inherent in forward-looking  statements, the inclusion
of any such statement should not be regarded as a representation  by the Company
or any  other  person  that  the  objectives  or plans  of the  Company  will be
achieved.  The Company  disclaims  any  obligation  or intent to update any such
factors or forward-looking  statements to reflect future events or developments.
See "Risk Factors."

                                   THE COMPANY

        Nu Skin Asia  Pacific is a rapidly  growing  network  marketing  company
involved in the distribution and sale of premium  quality,  innovative  personal
care and nutritional products. The Company is the exclusive distribution vehicle
for NSI in the countries of Japan,  Taiwan,  Hong Kong (including Macau),  South
Korea, Thailand and the Philippines, where the Company currently has operations,
and in Indonesia,  Malaysia,  the People's Republic of China ("PRC"),  Singapore
and Vietnam, where Nu Skin operations have not commenced. The Company's products
are specifically  designed for the network marketing  distribution  channel. The
Company markets its personal care products under the trademark "Nu Skin" and its
nutritional products under the trademark "Interior Design Nutritionals" ("IDN").
The Nu Skin personal care product lines  include  facial care,  body care,  hair
care and color cosmetics,  as well as specialty products such as sun protection,
oral  hygiene  and  fragrances.   The  IDN  product  lines  include  nutritional
supplements,  nutritious  and healthy  snacks,  sports and  fitness  nutritional
products, health solutions and botanical supplements.

        In Japan, Taiwan and Hong Kong, the Company currently offers most of the
Nu Skin personal care products and approximately  one-third of the IDN products,
including LifePak, one of the core IDN nutritional supplements.  In South Korea,
the Company currently offers approximately one-half of the Nu Skin personal care
products,  including most of the Nu Skin core facial and hair care products, and
LifePak. In Thailand and the Philippines, the Company currently offers one-third
of the Nu Skin personal  care  products,  including  most of the core facial and
hair care products,  and none of the nutritional products.  The Company believes
that it can  significantly  grow its  business  and  attract  new  customers  by
expanding  its product  offerings  in each of its markets to include more of the
existing Nu Skin personal  care and IDN  products.  In addition to expanding its
product  offerings  with existing Nu Skin  personal  care and IDN products,  the
Company intends to introduce new products tailored to specific markets.

        The Company believes it is one of the fastest growing network  marketing
companies in Asia.  Revenue increased 31.2% to $890.5 million for the year ended
December 31, 1997 from $678.6 million in 1996. Operating expenses have increased
with the growth of the Company's  revenue.  Net income  increased 14.6% to $93.6
million for the year ended  December  31, 1997 from $81.7  million in 1996.  The
Company's  network of  independent  distributors  has grown since the  Company's
inception in 1991 to more than 430,000 active  distributors as of March 5, 1998.
See "Risk Factors--Managing Growth."







        A great  deal of the  Company's  success  to date is the  result  of the
growth  of  its  Japanese  business,  which  can be  attributed  in  part  to an
increasing  awareness  of the Nu Skin and IDN  brands.  Significant  revenue was
recognized  from the outset of the Company's  operations in Japan in 1993 due to
the immediate  attention  given to the market by leading NSI  distributors  from
around the world.  Japan has continued to post strong financial  results for the
Company, with revenue increasing by approximately 58% in U.S. dollars and 75% in
local  currency  for  1997  compared  to 1996 and by  approximately  64% in U.S.
dollars and 90% in local currency compared to 1995. Given the size of the direct
selling  market in Japan,  management  believes that there is still  significant
opportunity for revenue growth in this market.

        NSI,   founded  in  1984,  is  engaged  in  selling  personal  care  and
nutritional  products and,  together with its  affiliates,  comprises one of the
largest network marketing  organizations in the world. NSI provides a high level
of support services to the Company,  including product development,  distributor
support services,  marketing and other managerial  support services.  Management
believes  that the  Company's  relationship  with NSI has allowed the Company to
increase  revenue  and net  income  at rates  that  otherwise  may not have been
possible.  See "Risk  Factors--Relationship  with and Reliance on NSI; Potential
Conflicts of Interest." On February 27, 1998,  the Company  entered into a Stock
Acquisition Agreement with the stockholders of NSI and certain affiliates of NSI
to acquire all of the capital  stock of NSI and certain  affiliates  of NSI. See
"Recent Developments."

        The Company was incorporated on September 4, 1996. On November 20, 1996,
the stockholders (the "Original Stockholders") of Nu Skin Japan Company, Limited
("Nu Skin Japan"), Nu Skin Taiwan,  Inc. ("Nu Skin Taiwan"),  Nu Skin Hong Kong,
Inc.  ("Nu Skin Hong Kong"),  Nu Skin Korea,  Inc. ("Nu Skin Korea") and Nu Skin
Personal Care (Thailand),  Inc. ("Nu Skin Thailand") contributed their shares of
capital  stock to the capital of the  Company in exchange  for shares of Class B
Common  Stock,  par value $.001 per share (the "Class B Common  Stock"),  of the
Company (the "Reorganization").  As a result of the Reorganization,  each of the
above-listed  companies  became a wholly-owned  subsidiary of the Company,  and,
together with Nu Skin  Philippines,  Inc., are referred to  collectively  as the
"Subsidiaries." As used herein, "Nu Skin Asia Pacific" or the "Company" means Nu
Skin Asia Pacific, Inc. and the Subsidiaries, collectively.

        The Company's  principal executive offices are located at 75 West Center
Street,  Provo,  Utah 84601,  and its  telephone  number is (801)  345-6100.  Nu
Skin(R), Interior Design Nutritionals(TM), IDN(R), a logo consisting of an image
of a gold fountain  with the words "Nu Skin" below it, and a logo  consisting of
the  stylized  letters  "IDN" in black and red are  trademarks  on NSI which are
licensed to the Company.  The italicized  product names used in this  Prospectus
are product names and also, in certain cases, trademarks and are the property of
NSI. All other  tradenames and trademarks  appearing in this  Prospectus are the
property of their respective holders.

                               RECENT DEVELOPMENTS

        On February  27,  1998,  the Company  entered  into a Stock  Acquisition
Agreement (the "Acquisition Agreement") with the stockholders of NSI and certain
affiliates of NSI (the "NSI  Stockholders")  to acquire (the "NSI  Acquisition")
all of the capital  stock of NSI and certain  affiliates  of NSI (the  "Acquired
Entities").  The consideration to be paid by the Company to the NSI Stockholders
will consist of shares of Series A Preferred  Stock,  par value $.001 per share,
of the Company (the "Series A Preferred  Stock") in an amount  determined as set
forth below, the assumption of the Acquired  Entities' S Distribution  Notes (as
defined below) payable to the NSI  Stockholders  in the amount of  approximately
$180.0 million (taking into account the Acquired  Entities' S Distribution Notes
in the amount of  approximately  $136.2  million  as of  December  31,  1997 and
additional  Acquired  Entities'  S  Distribution  Notes  covering  undistributed
earnings  for the period  commencing  January 1, 1998 and ending on the  closing
date of the NSI  Acquisition)  and,  contingent upon NSI and the Company meeting
certain  earnings  growth  targets,  up to $25 million in cash per year over the
next four years.  In addition,  the Acquisition  Agreement  provides that if the
Acquired Entities' S Distribution Notes for the above-referenced periods do not






equal or exceed $180.0  million,  the Company will pay each NSI  Stockholder  in
cash or in the form of promissory notes the difference  between (i) $180 million
and (ii) the aggregate principal amount of the Acquired Entities' S Distribution
Notes multiplied by each NSI Stockholder's  proportional  ownership  interest in
the outstanding  capital stock of NSI. The Acquisition  Agreement  provides that
the  number of shares of Series A  Preferred  Stock to be  delivered  to the NSI
Stockholders  shall be determined by dividing $70 million by the average closing
price of the Class A Common  Stock for the 20  consecutive  trading  days ending
five trading days prior to the closing of the NSI Acquisition.

        Collectively, the NSI Stockholders and their affiliates own beneficially
all of the outstanding shares of the Class B Common Stock. In addition,  several
of the NSI Stockholders are directors and/or executive officers of the Company.

        Effective  as of December  31,  1997,  NSI  contributed  certain  assets
relating to the right to distribute NSI products in the United States to Nu Skin
USA, Inc. ("Nu Skin USA"), a newly created  corporation  wholly owned by the NSI
Stockholders,  in exchange  for all of the common  stock of Nu Skin USA.  The Nu
Skin USA common stock was then distributed to the NSI Stockholders. In addition,
effective as of December 31, 1997, NSI and the other Acquired  Entities declared
distributions to their then existing stockholders  (consisting solely of the NSI
Stockholders) that included all of such Acquired Entities' previously earned and
undistributed S corporation  earnings through such date (the "Acquired Entities'
S Corporation  Distribution").  As of December 31, 1997, such Acquired Entities'
aggregate   undistributed  S  corporation  earnings  were  approximately  $136.2
million.  The Acquired  Entities' S Corporation  Distribution was distributed in
the form of promissory  notes due December 31, 2004 and bearing interest at 8.0%
per  annum  (the  "Acquired  Entities'  S  Distribution  Notes").  The  Acquired
Entities'  S  Corporation  Distribution  Notes  are  held  entirely  by the  NSI
Stockholders.  In addition,  the Acquired Entities will declare distributions to
then  existing   stockholders  that  include  all  of  such  Acquired  Entities'
previously earned and  undistributed S corporation  earnings through the date of
closing of the NSI Acquisition.  As discussed above, the obligation to repay the
Acquired  Entities' S Distribution Notes to the NSI Stockholders will be assumed
by the Company in connection with the NSI Acquisition.

        The Acquired Entities consist of NSI, Nu Skin  International  Management
Group, Inc., ("NSIMG") and the NSI affiliates operating in Europe, Australia and
New Zealand, including Nu Skin Europe, Inc.; Nu Skin U.K., Ltd. (domesticated in
Delaware under the name Nu Skin U.K., Inc.); Nu Skin Germany, GmbH (domesticated
in  Delaware  under  the  name Nu Skin  Germany,  Inc.);  Nu Skin  France,  SARL
(domesticated  in  Delaware  under  the  name Nu  Skin  France,  Inc.);  Nu Skin
Netherlands,  B.V. (domesticated in Delaware under the name Nu Skin Netherlands,
Inc.);  Nu Skin Italy,  (SRL)  (domesticated  in Delaware under the name Nu Skin
Italy,  Inc.); Nu Skin Spain,  S.L.  (domesticated in Delaware under the name Nu
Skin Spain,  Inc.); Nu Skin Belgium,  N.V.  (domesticated  in Delaware under the
name Nu Skin Belgium, Inc.); Nu Skin Personal Care Australia,  Inc.; Nu Skin New
Zealand, Inc.; Nu Skin Brazil, Ltda. (domesticated in Delaware under the name Nu
Skin Brazil, Inc.); Nu Skin Argentina,  Inc.; Nu Skin Chile, S.A.  (domesticated
in  Delaware  under  the  name  Nu  Skin  Chile,  Inc.);  Nu  Skin  Poland  Spa.
(domesticated  in  Delaware  under  the name Nu Skin  Poland,  Inc.);  and Cedar
Meadows,  L.C. The NSI Stockholders  continue to own as private entities the NSI
affiliates operating in the United States, Canada, Mexico,  Guatemala and Puerto
Rico,  including Nu Skin USA, Inc.; Nu Skin Canada, Inc.; Nu Skin Mexico S.A. de
C.V.  (domesticated  in Delaware under the name Nu Skin Mexico,  Inc.);  Nu Skin
Guatemala,  S.A.  (domesticated  in Delaware  under the name Nu Skin  Guatemala,
Inc.); and Nu Skin Puerto Rico, Inc. (collectively, the "Retained Entities").







        The following  chart  illustrates  the  organizational  structure of the
Company and the Retained Entities immediately after the NSI Acquisition.


                             [ORGANIZATIONAL CHART]


        Through its  acquisition  of NSI, the Company will obtain  ownership and
control  of  the  Nu  Skin  trademarks  and  tradenames,   the  Nu  Skin  Global
Compensation  Plan,  distributor  lists and related  intellectual  property  and
know-how (collectively,  the "Intellectual Property"). The Company, through NSI,
intends to continue to license the  Intellectual  Property and,  through  NSIMG,
intends to  continue to provide  management  support  services  to the  Acquired
Entities  on  substantially   the  same  terms  as  existed  prior  to  the  NSI
Acquisition.  In connection with the NSI Acquisition,  the Company  anticipates,
through NSI and NSIMG,  entering into new agreements  with Nu Skin USA, Inc. and
revised  agreements  with the other  Retained  Entities  on terms  substantially
similar to its agreements with the Acquired Entities, pursuant to which NSI will
continue to license the Intellectual Property and the exclusive right to sell Nu
Skin  personal  care and  nutritional  products  in the United  States,  Canada,
Mexico,  Guatemala  and  Puerto  Rico to the  Retained  Entities  and NSIMG will
continue to provide management support services to the Retained Entities.

        Upon completion of the NSI Acquisition, the Company and its subsidiaries
will own and  distribute Nu Skin products in 18 markets  worldwide.  The Company
will also hold the rights to all future Nu Skin markets.







                                  RISK FACTORS

        An  investment  in the  Class A Common  Stock  offered  hereby  involves
special  considerations  and significant risks,  including,  but not limited to,
those discussed or referred to below.  Prospective  investors  should  carefully
consider the  following  risks and  information  in  conjunction  with the other
information  contained in this  Prospectus  before  acquiring  shares of Class A
Common Stock. The risk factors set forth below relate to the Company's  business
prior to the  contemplated  NSI  Acquisition.  Certain of these  factors  may be
impacted by the proposed NSI  Acquisition;  however,  no assurance  can be given
that the NSI Acquisition will be consummated. See "Recent Developments."

Reliance Upon Independent Distributors of NSI

        The Company  distributes its products  exclusively  through  independent
distributors  who have  contracted  directly  with NSI to  become  distributors.
Consequently,  the Company  does not contract  directly  with  distributors  but
licenses its  distribution  system and distributor  force from NSI.  Distributor
agreements with NSI are voluntarily  terminable by distributors at any time. The
Company's  revenue is directly  dependent upon the efforts of these  independent
distributors,  and any growth in future sales volume will require an increase in
the  productivity  of these  distributors  and/or  growth in the total number of
distributors. As is typical in the direct selling industry, there is turnover in
distributors  from year to year,  which  requires the sponsoring and training of
new  distributors  by existing  distributors to maintain or increase the overall
distributor  force and  motivate  new and  existing  distributors.  The  Company
experiences  seasonal  decreases in distributor  sponsoring and product sales in
some of the countries in which the Company  operates  because of local  holidays
and customary  vacation periods.  The size of the distribution force can also be
particularly  impacted by general economic and business  conditions and a number
of intangible factors such as adverse publicity regarding the Company or NSI, or
the public's perception of the Company's products,  product  ingredients,  NSI's
distributors or direct selling businesses in general.  Historically, the Company
has experienced  periodic  fluctuations in the level of distributor  sponsorship
(as measured by  distributor  applications).  However,  because of the number of
factors that impact the  sponsoring of new  distributors,  and the fact that the
Company has little control over the level of  sponsorship  of new  distributors,
the Company cannot predict the timing or degree of those fluctuations. There can
be no assurance that the number or  productivity  of the Company's  distributors
will be sustained at current levels or increased in the future. In addition, the
number of  distributors  as a percentage of the population in a given country or
market could  theoretically  reach levels that become difficult to exceed due to
the  finite  number of  persons  inclined  to pursue a direct  selling  business
opportunity.  This is of particular  concern in Taiwan,  where industry  sources
have estimated that up to 10% of the population is already involved in some form
of direct selling.

        Since   distributor   agreements   are  entered  into  between  NSI  and
distributors,  all of the  distributors who generate revenue for the Company are
distributors  of NSI. See  "--Relationship  with and Reliance on NSI;  Potential
Conflicts of Interest." Because distributors are independent contractors of NSI,
neither  NSI nor the  Company  is in a  position  to  provide  the same level of
direction,  motivation  and  oversight  as either  would with respect to its own
employees.  The  Company  relies on NSI to  enforce  distributors  policies  and
procedures.  Although  NSI  has a  compliance  department  responsible  for  the
enforcement of the policies and procedures that govern distributor  conduct,  it
can be difficult to enforce these policies and  procedures  because of the large
number of distributors and their  independent  status,  as well as the impact of
regulations  in certain  countries that limit the ability of NSI and the Company
to monitor and control the sales practices of distributors.

Currency Risks

        The   Company's   foreign-derived   sales  and   selling,   general  and
administrative  expenses are converted to U.S.  dollars for reporting  purposes.
Consequently,  the Company's  reported  earnings are  significantly  impacted by
changes in currency exchange rates, generally increasing with a weakening dollar
and decreasing with a strengthening  dollar. In addition,  the Company purchases
inventory from NSI in U.S. dollars and assumes currency  exchange rate risk with
respect to such purchases. Local currency in Japan, Taiwan, Hong Kong, South






Korea,  Thailand and the  Philippines is generally used to settle  non-inventory
transactions  with NSI.  Given the  uncertainty  of the extent of exchange  rate
fluctuations,  the Company cannot  estimate the effect of these  fluctuations on
its future  business,  product  pricing,  results  of  operations  or  financial
condition.  However,  because nearly all of the Company's revenue is realized in
local  currencies  and the majority of its cost of sales is  denominated in U.S.
dollars,  the Company's gross profits will be positively affected by a weakening
in the U.S.  dollar and will be negatively  affected by a  strengthening  in the
U.S. dollar.

        The Company  believes that a variety of complex factors impact the value
of local currencies  relative to the U.S. dollar including,  without limitation,
interest rates, monetary policies, political environments, and relative economic
strengths.  The Company has been subject to  exceptionally  high  volatility  in
currency  exchange  rates in certain  markets during 1997. In order to partially
offset  the  anticipated  effect of these  currency  fluctuations,  the  Company
implemented a price  increase on certain of its products of between 5% and 9% on
average in 1997.  There can be no assurance  that future  currency  fluctuations
will not result in similar  concerns or adversely  affect the performance of the
price of the Class A Common  Stock.  Although  the  Company  tries to reduce its
exposure  to   fluctuations   in  foreign   exchange   rates  by  using  hedging
transactions,  such  transactions may not entirely offset the impact of currency
fluctuations.  Accordingly,  in the face of a strengthening  of the U.S. dollar,
the  Company's  earnings  will be adversely  affected.  The Company does not use
hedging transactions for trading or speculative purposes.

Risks Related to the Proposed NSI Acquisition

        The  Company  believes  that the  proposed  NSI  Acquisition  will offer
opportunities  for long-term  efficiencies in operations that should  positively
affect future results of the combined operations of the Company and the Acquired
Entities.  However, no assurances can be given whether or when such efficiencies
will be realized.  In addition,  the combined companies will be more complex and
diverse  than  the  Company  individually,  and the  combination  and  continued
operation  of  their  distinct   business   operations  will  present  difficult
challenges for the Company's  management due to the increased time and resources
required in the management  effort.  While management and the Board of Directors
of the Company  believe that the  combination  can be effected in a manner which
will increase the value of the Company and the Acquired  Entities,  no assurance
can given that such realization of value will be achieved.

        Although the parties to the NSI Acquisition have entered into definitive
agreements,  the  closing  of the  NSI  Acquisition  is  subject  to the  timely
satisfaction  of certain  conditions  contained  in the  Acquisition  Agreement.
Although the Company  currently  expects that such  closing  conditions  will be
satisfied  or  waived,  there can be no  assurance  that the  closing of the NSI
Acquisition will occur. Such conditions include, among others, the receipt of an
opinion  from the  Company's  independent  public  accountants  with  respect to
certain  tax  matters  of the NSI  Acquisition,  the  receipt  of all  necessary
consents and approvals from  governmental  officials and other third parties and
the absence of any material  adverse change in the business or operations of the
Acquired Entities.

Potential Effects of Adverse Publicity

        The size of the  distribution  force and the  results  of the  Company's
operations  can be  particularly  impacted by adverse  publicity  regarding  the
Company or NSI, or their competitors, including publicity regarding the legality
of  network  marketing,  the  quality  of the  Company's  products  and  product
ingredients  or  those  of its  competitors,  regulatory  investigations  of the
Company or the Company's competitors and their products, distributor actions and
the public's  perception of NSI's  distributors  and direct  selling  businesses
generally.

        In 1991 and 1992,  NSI was the  subject  of  investigations  by  various
regulatory  agencies of eight states. All of the  investigations  were concluded
satisfactorily.  However,  the  publicity  associated  with  the  investigations
resulted in a material adverse impact on NSI's results of operations. The denial
by  the  Malaysian   government  in  1995  of  the  Company's   business  permit
applications due to distributor  actions  resulted in adverse  publicity for the
Company.  See"--Potential  Negative  Impact of  Distributor  Actions."  In South
Korea, publicity generated by a






coalition of consumer groups targeted at a competitor of the Company  negatively
impacted  the  Company's  operations  in 1997.  In  addition,  the South  Korean
government and certain consumer and trade  organizations have expressed concerns
which have  attracted  media  attention  regarding  South Korean  consumption of
luxury and foreign products,  in general.  The Company believes that the adverse
publicity resulting from these claims and media campaigns has adversely affected
and may  continue  to  adversely  affect the  direct  selling  industry  and the
Company's  South  Korean   operations.   See   "--Seasonality  and  Cyclicality;
Variations in Operating  Results." The State of  Pennsylvania  recently filed an
action  against NSI for  alleged  violations  of  Pennsylvania  law  relating to
activities of Nu Skin distributors  promoting a business called Big Planet.  The
filing of the action  precipitated  certain negative media coverage and may have
an impact on the operations of the Company and its  affiliates.  There can be no
assurance  that the  Company  will not be subject to  adverse  publicity  in the
future as a result of  regulatory  investigations  or  actions,  whether  of the
Company or its competitors, distributor actions, actions of competitors or other
factors,  or that such adverse publicity will not have a material adverse effect
on the Company's business or results of operations. See "--Government Regulation
of  Direct  Selling  Activities,"   "--Government  Regulation  of  Products  and
Marketing; Import Restrictions," "--Other Regulatory Issues" and "--Entering New
Markets."

Potential Negative Impact of Distributor Actions

        Distributor  actions can negatively impact the Company and its products.
From time to time,  the Company  receives  inquiries  from  regulatory  agencies
precipitated by distributor actions. For example, in October 1995, the Company's
business  permit  applications  were denied by the  Malaysian  government as the
result of  activities by certain NSI  distributors  before  required  government
approvals  could be secured.  NSI  subsequently  terminated the  distributorship
rights of some of the  distributors  involved  and elected to withdraw  from the
Malaysian market for a period of time. The denial by the Malaysian government of
the Company's business permit applications resulted in adverse publicity for the
Company.  See  "--Other  Regulatory  Issues."  Distributor  activities  in other
countries in which the Company has not commenced operations may similarly result
in an  inability  to  secure,  or delay in  securing,  required  regulatory  and
business permits. In addition,  the publicity which can result from a variety of
potential distributor  activities such as inappropriate earnings claims, product
representations or improper  importation of Nu Skin products from other markets,
can make the sponsoring and retaining of distributors  more  difficult,  thereby
negatively  impacting  sales. See  "--Potential  Effects of Adverse  Publicity."
Furthermore, the Company's business and results of operations could be adversely
affected if NSI  terminates  a  significant  number of  distributors  or certain
distributors who play a key role in the Company's distribution system. There can
be no assurance that these or other distributor actions will not have a material
adverse effect on the Company's  business or results of  operations.  The recent
action  filed by the State of  Pennsylvania  against the Company  resulted  from
improper distributor actions. See "--Potential Effects of Adverse Publicity."

Seasonality and Cyclicality; Variations in Operating Results

        While neither seasonal nor cyclical  variations have materially affected
the Company's results of operations to date, the Company believes that its rapid
growth  may  have  overshadowed  these  factors.  Accordingly,  there  can be no
assurance that seasonal or cyclical  variations  will not  materially  adversely
affect the Company's results of operations in the future.

        The direct  selling  industry in Asia is  impacted  by certain  seasonal
trends such as major cultural events and vacation patterns.  For example,  sales
are generally  affected by local New Year  celebrations in Japan,  Taiwan,  Hong
Kong,  South Korea and  Thailand,  which occur in the Company's  first  quarter.
Management  believes that direct selling in Japan is also  generally  negatively
impacted during August, when many individuals traditionally take vacations.

        Generally,  the Company has experienced rapid revenue growth in each new
market from the commencement of operations.  In Japan, Taiwan and Hong Kong, the
initial  rapid  revenue  growth  was  followed  by a short  period  of stable or
declining   revenue   followed   by  renewed   growth   fueled  by  new  product
introductions,






an  increase  in the number of active  distributors  and  increased  distributor
productivity.  The Company's operations in South Korea experienced a significant
decline in 1997 which was due in part to a business  cycle common to new markets
opened by the Company but which was due  primarily to general  economic  turmoil
and adverse business conditions. See "--Potential Effects of Adverse Publicity."
An  additional  factor  which the Company  believes has  contributed  to revenue
decline in South Korea is the focus of key distributors on other recently-opened
markets, including Thailand.

        In addition,  the Company may  experience  variations  in its results of
operations,  on a quarterly basis as new products are introduced and new markets
are opened.  There can be no  assurance  that current  revenue and  productivity
trends will be  maintained  in any of these  markets or that  future  results of
operations will follow historical performance.

Government Regulation of Direct Selling Activities

        Direct  selling   activities  are  regulated  by  various   governmental
agencies.   These  laws  and  regulations  are  generally  intended  to  prevent
fraudulent or deceptive schemes, often referred to as "pyramid" or "chain sales"
schemes, that promise quick rewards for little or no effort,  require high entry
costs,  use high pressure  recruiting  methods and/or do not involve  legitimate
products.  In Japan,  the Company's  distribution  system is regulated under the
"Door-to-Door"  Sales Law, which requires the submission of specific information
concerning  the  Company's  business  and products  and which  provides  certain
cancellation  and  cooling-off   rights  for  consumers  and  new  distributors.
Management  has been advised by counsel that in some respects  Japanese laws are
becoming more  restrictive  with respect to direct selling in Japan.  In Taiwan,
the Fair Trade Law (and the  Enforcement  Rules and  Supervisory  Regulations of
Multi-Level  Sales) requires the Company to comply with registration  procedures
and also provides distributors with certain rights regarding cooling-off periods
and product  returns.  The  Company  also  complies  with South  Korea's  strict
Door-to-Door  Sales  Act,  which  requires,  among  other  things,  the  regular
reporting  of  revenue,  the  registration  of  distributors  together  with the
issuance of a registration  card, and the  maintaining of a current  distributor
registry.  This law also  limits the  amount of  commissions  that a  registered
multi-level marketing company can pay to its distributors to 35% of revenue in a
given  month.  In Thailand and the  Philippines,  general fair trade laws impact
direct selling and multi-level marketing activities.

        Based on research  conducted in opening its existing markets  (including
assistance  from  local  counsel),  the  nature  and  scope  of  inquiries  from
government  regulatory  authorities  and the Company's  history of operations in
such markets to date, the Company believes that its method of distribution is in
compliance in all material  respects with the laws and  regulations  relating to
direct selling activities of all of the countries in which the Company currently
operates.  Many countries,  however,  including Singapore,  one of the Company's
potential markets,  currently have laws in place that would prohibit the Company
and NSI from conducting business in such markets. There can be no assurance that
the  Company  will be allowed to conduct  business in each of the new markets or
continue to conduct  business in each of its existing markets licensed from NSI.
See "--Entering New Markets."

Government Regulation of Products and Marketing; Import Restrictions

        The Company and NSI are subject to or affected by extensive governmental
regulations not specifically  addressed to network  marketing.  Such regulations
govern,  among other things, (i) product  formulation,  labeling,  packaging and
importation,  (ii) product claims and advertising,  whether made by the Company,
NSI or NSI distributors, (iii) fair trade and distributor practices, (iv) taxes,
transfer pricing and similar  regulations that affect foreign taxable income and
customs duties, and (v) regulations governing foreign companies generally.

        With the exception of a small percentage of revenues in Japan, virtually
all  of the  Company's  sales  historically  have  been  derived  from  products
purchased from NSI. All of those products  historically  have been imported into
the  countries in which they were  ultimately  sold.  The countries in which the
Company  currently  conducts  business  impose  various  legal  restrictions  on
imports. In Japan, the Japanese Ministry of Health and Welfare ("MOHW") requires
the Company to possess an import business  license and to register each personal
care






product imported into the country.  Packaging and labeling requirements are also
specified.  The Company has had to  reformulate  many  products to satisfy  MOHW
regulations. In Japan, nutritional foods, drugs and quasi-drugs are all strictly
regulated.  The chief concern  involves the types of claims and  representations
that can be made regarding the efficacy of nutritional  products. In Taiwan, all
"medicated" cosmetic and pharmaceutical  products require registration.  In Hong
Kong and Macau,  "pharmaceutical"  products  are  strictly  regulated.  In South
Korea,  the Company is subject to and has obtained the mandatory  certificate of
confirmation  as a qualified  importer  of  cosmetics  under the  Pharmaceutical
Affairs  Law  as  well  as  additional  product  approvals  for  each  of the 45
categories  of cosmetic  products  which it imports.  Each new cosmetic  product
undergoes  a  60-day  post-customs  inspection  during  which,  in  addition  to
compliance  with  ingredient   requirements,   each  product  is  inspected  for
compliance with South Korean labeling requirements.  In Thailand,  personal care
products  are  regulated  by the Food and Drug  Association  and the Ministry of
Public Health and all of the Nu Skin  personal care products  introduced in this
market have qualified for simplified  approval procedures under Thai law. In the
Philippines,  Nu Skin  products are regulated by the Bureau of Food and Drug and
all products  introduced  in this market have been  registered.  There can be no
assurance  that  these or other  applicable  regulations  will not  prevent  the
Company  from   introducing  new  products  into  its  markets  or  require  the
reformulation of existing products.

        The Company has not  experienced  any difficulty  maintaining its import
licenses but has experienced  complications regarding health and safety and food
and  drug   regulations  for  nutritional   products.   Many  products   require
reformulation to comply with local  requirements.  In addition,  new regulations
could be adopted or any of the existing regulations could be changed at any time
in a manner that could have a material adverse effect on the Company's  business
and results of  operations.  Duties on imports are a component of national trade
and  economic  policy and could be changed in a manner that would be  materially
adverse  to the  Company's  sales  and  its  competitive  position  compared  to
locally-produced  goods,  in particular in countries  such as Taiwan,  where the
Company's  products  are already  subject to high customs  duties.  In addition,
import  restrictions in certain countries and jurisdictions  limit the Company's
ability to import  products  from NSI. In some  jurisdictions,  such as the PRC,
regulators may prevent the  importation of Nu Skin and IDN products  altogether.
Present or future health and safety or food and drug regulations  could delay or
prevent the  introduction of new products into a given country or marketplace or
suspend  or  prohibit  the  sale  of  existing   products  in  such  country  or
marketplace.

Other Regulatory Issues

        As  a  U.S.   entity   operating   through   subsidiaries   in   foreign
jurisdictions,  the Company is subject to foreign  exchange control and transfer
pricing laws that  regulate the flow of funds between the  Subsidiaries  and the
Company,  as well as the flow of funds to NSI for product purchases,  management
services and contractual obligations such as payment of distributor commissions.
The Company believes that it operates in compliance with all applicable customs,
foreign  exchange control and transfer  pricing laws.  However,  there can be no
assurance  that  the  Company  will  continue  to be found  to be  operating  in
compliance with foreign customs,  exchange control and transfer pricing laws, or
that such laws will not be modified,  which, as a result, may require changes in
the Company's operating procedures.

        As is the  case  with  most  network  marketing  companies,  NSI and the
Company  have from  time to time  received  inquiries  from  various  government
regulatory  authorities  regarding the nature of their business and other issues
such as compliance with local business opportunity and securities laws. Although
to date none of these inquiries has resulted in a finding  materially adverse to
the  Company  or NSI,  adverse  publicity  resulting  from  inquiries  into  NSI
operations by certain government agencies in the early 1990's,  stemming in part
out of  inappropriate  product and earnings claims by  distributors,  materially
adversely  affected NSI's  business and results of  operations.  There can be no
assurance that the Company or NSI will not face similar  inquiries in the future
which,  either as a result of  findings  adverse  to the  Company or NSI or as a
result of adverse  publicity  resulting from the  instigation of such inquiries,
could have a material  adverse  effect on the Company's  business and results of
operations. See "--Potential Effects of Adverse Publicity."







        The  Subsidiaries  are  periodically  subject to  reviews  and audits by
various governmental  agencies,  particularly in new markets,  where the Company
has  experienced  high rates of growth.  Recently,  the South Korean Ministry of
Trade,  Industry and Energy  commenced an examination of the largest foreign and
domestic  owned network  marketing  companies in South Korea,  including Nu Skin
Korea.  The  purposes  of the  examination  were  stated  to be to  monitor  how
companies are operating and to audit current business practices. In addition, Nu
Skin Korea has been  subject to an audit by the South  Korean  Customs  Service.
Management  believes that this audit was precipitated  largely as a result of Nu
Skin Korea's rapid growth and its position as the largest  importer of cosmetics
and  personal  care  products in South Korea as well as by recent  South  Korean
trade imbalances.  The Customs Service reviewed a broad range of issues relating
to the operations of Nu Skin Korea,  with a focus on reviewing customs valuation
issues and  intercompany  payments.  Recently,  the Customs Service has resolved
certain issues related to its audit without imposing sanctions. The intercompany
payment issue was referred to various other government  agencies which have also
recently  concluded their reviews and found no wrong-doing and imposed no fines,
sanctions or other restrictions.  The import valuation issues,  which management
considers to be routine in light of the  Company's  extensive  import and export
activities,  were referred to the valuation division of the Customs Service. The
Company  continues to believe that its actions  have been in  compliance  in all
material respects with relevant regulations. See "--Potential Negative Impact of
Distributor Actions." Management believes that other major importers of cosmetic
products are also the focus of regulatory reviews by South Korean authorities.

        Businesses  which  are more  than  50%  owned  by  non-citizens  are not
permitted  to operate in  Thailand  unless they have an Alien  Business  Permit,
which is  frequently  difficult to obtain.  The Company is  currently  operating
under the Treaty of Amity and Economic Relations between Thailand and the United
States (the  "Treaty of Amity").  Under the Treaty of Amity,  an Alien  Business
Permit is not required if a Thailand business is owned by an entity organized in
the United  States,  a majority of whose  owners are U.S.  citizens or entities.
From  time to time,  it has  been  reported  that  certain  Thailand  government
officials have  considered  supporting  the  termination of the Treaty of Amity.
There can be no  assurance  that,  if the Treaty of Amity were  terminated,  the
Company would be able to obtain an Alien Business Permit and continue operations
in Thailand.

        Based on the  Company's  and NSI's  experience  and research  (including
assistance  from counsel) and the nature and scope of inquiries from  government
regulatory  authorities,  the Company believes that it is in material compliance
with all regulations applicable to the Company.  Despite this belief, either the
Company or NSI could be found not to be in  material  compliance  with  existing
regulations as a result of, among other things, the considerable  interpretative
and  enforcement  discretion  given to regulators  or misconduct by  independent
distributors.  In 1994, NSI and three of its distributors entered into a consent
decree with the United States Federal Trade  Commission (the "FTC") with respect
to its  investigation  of  certain  product  claims and  distributor  practices,
pursuant  to  which  NSI  paid  approximately  $1  million  to  settle  the  FTC
investigation.  In  August  1997,  NSI  reached a  settlement  with the FTC with
respect  to certain  product  claims and its  compliance  with the 1994  consent
decree  pursuant  to which  settlement  NSI paid  $1.5  million  to the FTC.  In
connection  with the August  1997  settlement,  NSI also  voluntarily  agreed to
recall and rewrite virtually all of its sales and marketing materials to address
FTC  concerns.  In  February  1998,  the State of  Pennsylvania  filed a lawsuit
against NSI and one of its affiliates Big Planet, Inc. ("Big Planet"),  alleging
violations of  Pennsylvania  law. In early March 1998, NSI and Big Planet agreed
to suspend for 30 days all sales and recruitment efforts related to Big Planet's
potential  electricity  marketing program.  Big Planet also volunteered  certain
other  restrictions  on its  business.  NSI's primary  business of  distributing
personal care and  nutritional  products was  unaffected  by the lawsuit.  These
events were reported in certain media.

        Even though  neither the Company nor the  Subsidiaries  has  encountered
similar regulatory concerns, there can be no assurances that the Company and the
Subsidiaries   will  not  be  subject  to  similar   inquiries  and   regulatory
investigations  or disputes and the effects of any adverse  publicity  resulting
therefrom.  Any assertion or determination  that either the Company,  NSI or any
NSI distributors  are not in compliance with existing laws or regulations  could
potentially have a material adverse effect on the Company's business and results
of operations. In addition, in any country or jurisdiction,  the adoption of new
laws or regulations or changes in the interpretation






of existing laws or regulations could generate negative  publicity and/or have a
material adverse effect on the Company's business and results of operations. The
Company  cannot  determine  the  effect,   if  any,  that  future   governmental
regulations  or  administrative  orders may have on the  Company's  business and
results of operations. Moreover, governmental regulations in countries where the
Company  plans to  commence or expand  operations  may  prevent,  delay or limit
market entry of certain products or require the  reformulation of such products.
Regulatory action, whether or not it results in a final determination adverse to
the  Company  or NSI,  has the  potential  to create  negative  publicity,  with
detrimental  effects on the motivation  and  recruitment  of  distributors  and,
consequently,  on the Company's sales and earnings.  See "--Potential Effects of
Adverse Publicity" and "--Entering New Markets."

Reliance on Certain  Distributors;  Potential  Divergence  of Interests  between
Distributors and the Company

        The  Global   Compensation  Plan  allows  distributors  to  sponsor  new
distributors.  The sponsoring of new distributors  creates multiple  distributor
levels in the network marketing structure.  Sponsored  distributors are referred
to as "downline"  distributors  within the  sponsoring  distributor's  "downline
network." If downline  distributors  also sponsor new  distributors,  additional
levels of downline  distributors are created, with the new downline distributors
also becoming part of the original sponsor's  "downline network." As a result of
this network marketing  distribution system,  distributors develop relationships
with other  distributors,  both within their own countries and  internationally.
The Company believes that its revenue is generated from thousands of distributor
networks.  However,  the  Company  estimates  that,  as of  December  31,  1997,
approximately  300  distributorships   worldwide  comprised  NSI's  two  highest
executive   distributor   levels   (Hawaiian   Blue  Diamond  and  Blue  Diamond
distributors). These distributorships have developed extensive downline networks
which consist of thousands of sub-networks.  Together with such networks,  these
distributorships  account  for  substantially  all  of  the  Company's  revenue.
Consequently,  the  loss  of  such  a  high-level  distributor  or  another  key
distributor  together with a group of leading distributors in such distributor's
downline  network,  or the loss of a significant  number of distributors for any
reason,  could  adversely  affect sales of the  Company's  products,  impair the
Company's ability to attract new distributors and adversely impact earnings.

        Under the Global Compensation Plan, a distributor  receives  commissions
based  on  products  sold  by  the   distributor  and  by  participants  in  the
distributor's  worldwide  downline  network,  regardless of the country in which
such participants are located. The Company, on the other hand, receives revenues
based  almost  exclusively  on sales of  products  to  distributors  within  the
Company's markets. So, for example, if a distributor located in Japan sponsors a
distributor in Europe, the Japanese  distributor could receive commissions based
on the sales made by the European distributor, but the Company would not receive
any revenue  since the products  would have been sold  outside of the  Company's
markets.  The  interests  of the  Company  and  distributors  therefore  diverge
somewhat in that the  Company's  primary  objective is to maximize the amount of
products sold within the Company's markets, while the distributors' objective is
to maximize the amount of products sold by the participants in the distributors'
worldwide  downline  networks.  The  Company  and NSI  have  observed  that  the
commencement  of  operations in a new country tends to distract the attention of
distributors  from the  established  markets  for a  period  of time  while  key
distributors begin to build their downline networks within the new country.  NSI
is currently contemplating opening operations in additional countries outside of
the  Company's  markets.  To the extent  distributors  focus  their  energies on
establishing downline networks in these new countries,  and decrease their focus
on building  organizations  within the Company's markets, the Company's business
and results of operations could be adversely affected.  Furthermore, the Company
itself is currently contemplating opening new markets. In the event distributors
focus  on these  new  markets,  sales in  existing  markets  might be  adversely
affected.  There can be no assurance that these new markets will develop or that
any  increase in sales in new markets will not be more than offset by a decrease
in sales in the Company's existing markets.

Entering New Markets

        As part of its growth  strategy,  the Company has acquired  from NSI the
right to act as NSI's exclusive distribution vehicle in Indonesia, Malaysia, the
PRC, Singapore and Vietnam. The Company has undertaken






reviews of the laws and regulations to which its operations  would be subject in
Indonesia,  Malaysia,  the PRC, Singapore and Vietnam. Given existing regulatory
environments and economic conditions,  the Company's entrance into Singapore and
Vietnam  is not  anticipated  in the  short  to  mid-term.  The  regulatory  and
political  climate in the other countries for which the Company has the right to
act as NSI's  exclusive  distributor is such that a replication of the Company's
current operating structure cannot be guaranteed. Because the Company's personal
care and nutritional  product lines are positioned as premium product lines, the
market  potential for the Company's  product lines in relatively  less developed
countries, such as the PRC and Vietnam, remains to be determined.  Modifications
to each product line may be needed to accommodate the market  conditions in each
country, while maintaining the integrity of the Company's products. No assurance
can be given  that  the  Company  will be able to  obtain  necessary  regulatory
approvals  to  commence  operations  in these new  markets,  or that,  once such
approvals are  obtained,  the Company and NSI, upon which the Company is largely
dependent  for  product  development  assistance,  will be able to  successfully
reformulate  Nu Skin personal care and IDN product lines in any of the Company's
new markets to attract local consumers.

        Each  of  the  proposed  new  markets  will  present  additional  unique
difficulties  and  challenges.  The  PRC,  for  example,  has  proven  to  be  a
particularly  difficult  market for foreign  corporations  due to its  extensive
government  regulation and historical  political tenets, and no assurance can be
given that the Company will be able to establish Nu Skin  operations  in the PRC
using the  Company's  business  model or  otherwise.  The Company  believes that
entering the PRC may require the  successful  establishment  of a joint  venture
enterprise with a Chinese partner and the establishment of a local manufacturing
presence.  These initiatives would likely require a significant  investment over
time by the  Company.  The Company  believes  that the PRC  national  regulatory
agency  responsible  for direct selling  periodically  reviews the regulation of
multi-level marketing.  Management is aware of recent media and other reports in
the PRC reporting an increasing desire on the part of senior government officers
to curtail or even abolish direct selling and multi-level  marketing activities.
These views may lead to changes in applicable regulations.  The Company believes
that PRC  regulators  are currently not issuing  direct  selling or  multi-level
marketing  licenses  and may take action  restricting  or  rescinding  currently
licensed direct selling businesses. The Company is actively working on these and
other issues  including  joint  ventures and  potential  marketing  alternatives
related  to  possible  Nu Skin  operations  in the PRC.  It is not known when or
whether  the  Company  will be  able to  implement  in the PRC  business  models
consistent  with those used by the Company in other  markets.  The Company  will
likely  have to apply for  licenses on a province  by  province  basis,  and the
repatriation  of the  Company's  profits  will be  subject  to  restrictions  on
currency  conversion and the fluctuations of the government  controlled exchange
rate.  In  addition,  because  distribution  systems  in  the  PRC  are  greatly
fragmented,  the  Company  may be forced to use  business  models  significantly
different from those used by the Company in more developed  countries.  The lack
of a comprehensive  legal system,  the  uncertainties of enforcement of existing
legislation  and laws,  and  potential  revisions of existing laws could have an
adverse effect on the Company's proposed business in the PRC.

        The other  potential  new markets also present  significant  regulatory,
political  and economic  obstacles to the Company.  In  Singapore,  for example,
network   marketing  is  currently  illegal  and  is  not  permitted  under  any
circumstances.   Although  the  Company  believes  that  this  restriction  will
eventually  be  relaxed  or  repealed,  no  assurance  can be  given  that  such
regulation will not remain in place and that the Company will not be permanently
prevented  from  initiating  sales  in  Singapore.  In  addition,  Malaysia  has
governmental  guidelines that have the effect of limiting  foreign  ownership of
direct selling companies operating in Malaysia to no more than 30%. There can be
no  assurance  that the  Company  will be able to properly  structure  Malaysian
operations  to comply  with this  policy.  In  October  of 1995,  the  Company's
business permit applications were denied by the Malaysian government as a result
of activities by certain NSI distributors.  Therefore, the Company believes that
although  significant  opportunities  exist to expand  its  operations  into new
markets,  there can be no assurance  that these or other  difficulties  will not
prevent the Company from realizing the benefits of this opportunity.







Managing Growth

        The Company has experienced  rapid growth since  operations in Hong Kong
commenced in 1991.  The  management  challenges  imposed by this growth  include
entry into new  markets,  growth in the number of  employees  and  distributors,
expansion  of  facilities  necessary to  accommodate  growth and  additions  and
modifications   to  the  Company's   product  lines.  To  manage  these  changes
effectively,  the  Company may be required  to hire  additional  management  and
operations  personnel and to improve its  operational,  financial and management
systems.

Possible Adverse Effect on the Company of the Change in the Status of Hong Kong

        The Company has  offices and a portion of its  operations  in Hong Kong.
Effective  July 1,  1997,  the  exercise  of  sovereignty  over  Hong  Kong  was
transferred  from the  Government  of the United  Kingdom of Great  Britain  and
Northern Ireland (the "United  Kingdom"),  to the government of the PRC pursuant
to the Sino-British  Joint  Declaration on the Question of Hong Kong (the "Joint
Declaration"),  and Hong Kong became a Special  Administrative Region ("SAR") of
the PRC. The Joint Declaration  provided for Hong Kong to be under the authority
of the  government of the PRC but Hong Kong will enjoy a high degree of autonomy
except in  foreign  and  defense  affairs,  and that  Hong  Kong be vested  with
executive,  legislative and independent  judicial power.  The Joint  Declaration
also  provides  that the current  social and economic  systems in Hong Kong will
remain unchanged for 50 years after June 30, 1997 and that Hong Kong will retain
the status of an  international  financial  center.  Although sales in Hong Kong
accounted for less than 5% of the Company's revenues for the year ended December
31, 1997,  Hong Kong serves as the location for the Company's  regional  offices
and an important base of operations  for many of the Company's  most  successful
distributors  whose  downline  distributor  networks  extend  into  other  Asian
markets. Any adverse effect on the social, political or economic systems in Hong
Kong resulting  from this transfer  could have a material  adverse effect on the
Company's  business  and results of  operations.  Although  the Company does not
anticipate any material adverse change in the business  environment in Hong Kong
resulting  from the 1997  transfer of  sovereignty,  the Company has  formulated
contingency  plans  to  transfer  the  Company's   regional  office  to  another
jurisdiction  in the  event  that  the  Hong  Kong  business  environment  is so
affected.

Relationship with and Reliance on NSI; Potential Conflicts of Interest

        NSI has ownership  and control of the NSI  trademarks,  tradenames,  the
Global  Compensation  Plan,  the  Licensed  Property and licenses to the Company
rights to use the Licensed  Property in certain markets.  NSI and its affiliates
currently operate in 17 countries,  excluding the countries in which the Company
currently  operates,  and will continue to market and sell Nu Skin personal care
and IDN  nutritional  products  in  these  countries,  as well as in  additional
countries  outside of the  Company's  markets,  through  the  network  marketing
channel.  Thus,  the Company  cannot use the NSI trademarks to expand into other
markets for which the Company does not  currently  have a license  without first
obtaining  additional  licenses  or  other  rights  from  NSI.  There  can be no
assurance that NSI will make any additional  markets available to the Company or
that the terms of any new licenses  from NSI will be  acceptable to the Company.
See "Recent Developments."

        NSI has licensed to the  Company,  through the  Subsidiaries,  rights to
distribute  Nu Skin and IDN  products  and to use the  Licensed  Property in the
Company's  markets,  and NSIMG,  an  affiliate of NSI,  will provide  management
support services to the Company and the Subsidiaries,  pursuant to distribution,
trademark/tradename  license,  licensing  and  sales,  and  management  services
agreements (the "Operating Agreements"). The Company relies on NSI for research,
development,  testing,  labeling and regulatory  compliance for products sold to
the  Company  under  the  distribution  agreements,  and  virtually  all  of the
Company's  revenues are derived from products and sales aids  purchased from NSI
pursuant to these  agreements.  NSIMG  provides  the  Company  with a variety of
management and consulting services,  including,  but not limited to, management,
legal, financial, marketing and distributor support/training,  public relations,
international   expansion,   human  resources,   strategic   planning,   product
development  and  operations  administration  services.  Each  of the  Operating
Agreements (other than the distribution,






trademark/tradename  license  and  licensing  and sales  agreements  for Nu Skin
Korea, which have shorter terms), is for a term ending December 31, 2016, and is
subject to renegotiation after December 31, 2001, in the event that the Original
Stockholders and their affiliates,  on a combined basis, no longer  beneficially
own a majority of the combined voting power of the outstanding  shares of Common
Stock of the  Company  or of the  common  stock of NSI.  The  Company  is almost
completely dependent on the Operating Agreements to conduct its business, and in
the event NSI is  unable or  unwilling  to  perform  its  obligations  under the
Operating  Agreements,  or  terminates  the  Operating  Agreements  as  provided
therein,  the  Company's  business and results of  operations  will be adversely
affected. See "Recent Developments."

        After  consummation  of the NSI  Acquisition,  approximately  98% of the
combined voting power of the outstanding  shares of Common Stock will be held by
the Original  Stockholders and certain of their  affiliates.  Consequently,  the
Original  Stockholders  and certain of their  affiliates  will have the ability,
acting in concert,  to elect all directors of the Company and approve any action
requiring approval by a majority of the stockholders of the Company.  Certain of
the Original  Stockholders also own 100% of the outstanding  shares of NSI. As a
result of this  ownership,  and if the NSI Acquisition is not  consummated,  the
Original  Stockholders  who are  also  shareholders  of NSI  will  consider  the
short-term  and  the  long-term  impact  of  all  stockholder  decisions  on the
consolidated  financial  results  of NSI  and the  Company.  See  "--Control  by
Original Stockholders; Anti-Takeover Effects of Dual Classes of Common Stock."

        The Operating  Agreements were approved by the Board of Directors of the
Company,  which was,  except  with  respect  to the  approval  of the  Operating
Agreements with Nu Skin Thailand and Nu Skin  Philippines,  composed entirely of
individuals  who  were  also  officers  and  shareholders  of NSI at the time of
approval. The Operating Agreements with Nu Skin Thailand and Nu Skin Philippines
were approved by a majority of the  disinterested  directors of the Company.  In
addition,  some of the  executive  officers of the  Company  are also  executive
officers  of NSI.  It is  expected  that a  number  of the  Company's  executive
officers  will  continue to spend a portion of their time on the affairs of NSI,
for which they will continue to receive compensation from NSI.

        In view of the  substantial  relationships  between the Company and NSI,
conflicts  of interest  may exist or arise with  respect to existing  and future
business dealings,  including,  without  limitation,  the relative commitment of
time and energy by the executive  officers to the  respective  businesses of the
Company  and NSI,  potential  acquisitions  of  businesses  or  properties,  the
issuance of additional  securities,  the election of new or additional directors
and the payment of dividends by the Company.  There can be no assurance that any
conflicts of interest will be resolved in favor of the Company.  Under  Delaware
and Utah  law,  a person  who is a  director  of both the  Company  and NSI owes
fiduciary duties to both  corporations and their respective  shareholders.  As a
result,  persons who are  directors  of both the Company and NSI are required to
exercise  their  fiduciary  duties in light of what they  believe to be best for
each of the companies and its shareholders.

Control by Original Stockholders; Anti-Takeover Effect of Dual Classes of Common
Stock

        Because of the  relationship  between the  Company  and NSI,  management
elected to structure  the  capitalization  of the Company in such a manner as to
minimize  the  possibility  of a change in control of the  Company  without  the
consent of the Original Stockholders. Consequently, the shares of Class B Common
Stock enjoy ten to one voting privileges over the shares of Class A Common Stock
until the outstanding shares of Class B Common Stock constitute less than 10% of
the  total  outstanding  shares  of  Common  Stock.  After  consummation  of the
Offerings,  and the NSI  Acquisition,  the Original  Stockholders and certain of
their  affiliates will  collectively  own 100% of the outstanding  shares of the
Class B Common  Stock,  representing  approximately  98% of the combined  voting
power of the  outstanding  shares of Common  Stock.  Accordingly,  the  Original
Stockholders  and certain of their  affiliates,  acting  fully or  partially  in
concert, will have the ability to control the election of the Board of Directors
of the  Company  and thus the  direction  and future  operations  of the Company
without the supporting vote of any other  stockholder of the Company,  including
decisions  regarding   acquisitions  and  other  business   opportunities,   the
declaration of dividends and the issuance of additional shares of Class A Common
Stock and other securities.  NSI is a privately-held  company, all of the shares
of which are owned prior to consummation






of the NSI Acquisition by certain of the Original  Stockholders.  As long as the
shareholders  of NSI prior to  consummation  of the NSI Acquisition are majority
stockholders  of the Company,  assuming they act in concert,  third parties will
not be able to obtain  control of the  Company  through  purchases  of shares of
Class A Common Stock. See "Description of Capital Stock."

Adverse Impact on Company Income Due to Distributor Option Program

        Prior to the Underwritten Offerings, the Original Stockholders converted
1,605,000 shares of Class B Common Stock to Class A Common Stock and contributed
such shares of Class A Common Stock to the Company.  The Company  granted to NSI
options  to  purchase  such  shares of Class A Common  Stock  (the  "Distributor
Options"),  and NSI offered these options to qualifying distributors of NSI. The
Exercise Price for each Distributor Option is $5.75, which is 25% of the initial
price per share to the  public of the Class A Common  Stock in the  Underwritten
Offerings.  The Distributor Options vested December 31,1997. The shares of Class
A Common Stock underlying the Distributor  Options have been registered pursuant
to Rule 415 under the 1933 Act.

        The Company  incurred a total pre-tax non-cash  compensation  expense of
$19.9  million in connection  with the grant of the  Distributor  Options.  This
non-cash  compensation  expense resulted in a corresponding impact on net income
and net income per share.

Reliance on and Concentration of Outside Manufacturers

        Virtually  all the  Company's  products are sourced  through NSI and are
produced by  manufacturers  unaffiliated  with NSI.  The Company  currently  has
little or no direct  contact  with these  manufacturers.  The  Company's  profit
margins and its ability to deliver its  existing  products on a timely basis are
dependent upon the ability of NSI's outside  manufacturers to continue to supply
products  in a timely and  cost-efficient  manner.  Furthermore,  the  Company's
ability to enter new markets and  sustain  satisfactory  levels of sales in each
market is dependent in part upon the ability of suitable  outside  manufacturers
to reformulate existing products,  if necessary to comply with local regulations
or market  environments,  for  introduction  into  such  markets.  Finally,  the
development  of additional new products in the future will likewise be dependent
in part on the services of suitable outside manufacturers.

        The  Company  currently  acquires  products  or  ingredients  from  sole
suppliers or  suppliers  that are  considered  by the Company to be the superior
suppliers of such  ingredients.  The Company  believes  that, in the event it is
unable to source any products or  ingredients  from its current  suppliers,  the
Company  could  produce  such  products or replace such  products or  substitute
ingredients  without great  difficulty or  prohibitive  increases in the cost of
goods sold. However,  there can be no assurance that the loss of such a supplier
would not have a material  adverse effect on the Company's  business and results
of operations.

        With  respect  to sales to the  Company,  NSI  currently  relies  on two
unaffiliated  manufacturers to produce approximately 70% and 80% of its personal
care and nutritional  products,  respectively.  NSI has a written agreement with
the primary supplier of the Company's personal care products that expires at the
end of 2000. An extension to such contract is currently  being  negotiated.  NSI
does not  currently  have a written  contract  with the primary  supplier of the
Company's  nutritional  products.  The Company  believes  that in the event that
NSI's relationship with any of its key manufacturers is terminated,  NSI will be
able  to find  suitable  replacement  manufacturers.  However,  there  can be no
assurance that the loss of either manufacturer would not have a material adverse
effect on the Company's business and results of operations.

Reliance on Operations of and Dividends and Distributions from Subsidiaries

        The  Company  is a  holding  company  without  operations  of its own or
significant  assets other than ownership of 100% of the capital stock of each of
the Subsidiaries.  Accordingly, an important source of the Company's income will
be  dividends  and  other  distributions  from  the  Subsidiaries.  Each  of the
Subsidiaries has






its operations in a country other than the United  States,  the country in which
the Company is organized.  In addition,  each of the  Subsidiaries  receives its
revenues in the local  currency of the  country or  jurisdiction  in which it is
situated.  As a consequence,  the Company's ability to obtain dividends or other
distributions is subject to, among other things, restrictions on dividends under
applicable local laws and regulations, and foreign currency exchange regulations
of  the  country  or  jurisdictions  in  which  the  Subsidiaries  operate.  The
Subsidiaries'  ability  to pay  dividends  or make  other  distributions  to the
Company is also subject to their having  sufficient  funds from their operations
legally  available for the payment of such dividends or  distributions  that are
not  needed to fund  their  operations,  obligations  or other  business  plans.
Because the  Company  will be a  stockholder  of each of the  Subsidiaries,  the
Company's  claims as such will generally  rank junior to all other  creditors of
and claims against the Subsidiaries. In the event of a Subsidiary's liquidation,
there may not be assets  sufficient  for the Company to recoup its investment in
such Subsidiary.

Taxation Risks and Transfer Pricing

        The  Company is subject to taxation  in the United  States,  where it is
incorporated,  at a  statutory  corporate  federal  tax rate of  35.0%  plus any
applicable  state income  taxes.  In  addition,  each  Subsidiary  is subject to
taxation in the country in which it operates, currently ranging from a statutory
tax rate of 57.9% in Japan to 16.5% in Hong Kong.  The  Company is  eligible  to
receive foreign tax credits in the U.S. for the amount of foreign taxes actually
paid in a given period.  In the event that the Company's  operations in high tax
jurisdictions such as Japan grow disproportionately to the rest of the Company's
operations,  the Company will be unable to fully utilize its foreign tax credits
in the U.S.,  which could,  accordingly,  result in the Company  paying a higher
overall effective tax rate on its worldwide operations.

        Because  the  Subsidiaries  operate  outside of the United  States,  the
Company is subject to the jurisdiction of numerous  foreign tax authorities.  In
addition to closely monitoring the Subsidiaries' locally based income, these tax
authorities  regulate and restrict  various  corporate  transactions,  including
intercompany  transfers.  The Company believes that the tax authorities in Japan
and South Korea are  particularly  active in  challenging  the tax structures of
foreign corporations and their intercompany transfers.  The Company is currently
undergoing  a customs  audit in South Korea.  See  "--Government  Regulation  of
Products and Marketing;  Import  Restrictions" and "--Other  Regulatory Issues."
Although the Company believes that its tax and transfer  pricing  structures are
in compliance in all material  respects with the laws of every  jurisdiction  in
which it operates,  no assurance can be given that these  structures will not be
challenged by foreign tax  authorities  or that such  challenges or any required
changes  in such  structures  will not have a  material  adverse  effect  on the
Company's business or results of operations.

Increase in Distributor Compensation Expense

        Under the  Licensing  and Sales  Agreements  (the  "Licensing  and Sales
Agreements") between each of the Subsidiaries and NSI, the Company,  through its
Subsidiaries, is contractually obligated to pay a distributor commission expense
of 42% of commissionable product sales (with the exception of South Korea where,
due to government  regulations,  the Company uses a formula based upon a maximum
payout  of 35%  of  commissionable  product  sales).  The  Licensing  and  Sales
Agreements  provide  that the Company is to satisfy  this  obligation  by paying
commissions  owed to local  distributors.  In the event that  these  commissions
exceed 42% of  commissionable  product sales, the Company is entitled to receive
the difference from NSI. In the event that the  commissions  paid are lower than
42%, the Company must pay the  difference to NSI.  Under this  formulation,  the
Company's total  commission  expense is fixed at 42% of  commissionable  product
sales in each country  (except for South Korea).  The 42% figure has been set on
the basis of NSI's  experience  over the past eight years  during  which  period
actual  commissions paid in a given year together with the cost of administering
the Global  Compensation  Plan have ranged between 41% and 43% of commissionable
product  sales for such year  (averaging  approximately  42%). In the event that
actual  commissions  payable to distributors from sales in the Company's markets
vary  from  these  historical  results,  whether  as  a  result  of  changes  in
distributor  behavior or changes to the Global Compensation Plan or in the event
that NSI's cost of administering the Global Compensation Plan increases






or decreases,  the Licensing and Sales Agreements  provide that the intercompany
settlement  figure may be modified to more  accurately  reflect actual  results.
This could result in the Company becoming  obligated to make greater  settlement
payments  to NSI  under the  Licensing  and Sales  Agreements.  Such  additional
payments could adversely affect the Company's results of operations. Because the
Company  licenses  the right to use the Global  Compensation  Plan from NSI, the
structure of the plan, including commission rates, is under the control of NSI.

Product Liability

        The Company may be subject,  under applicable laws and  regulations,  to
liability for loss or injury caused by its products.  The Company's Subsidiaries
are currently  covered for product  liability  claims to the extent of and under
insurance  programs  maintained  by NSI for their benefit and for the benefit of
its  affiliates  purchasing  NSI products.  Accordingly,  NSI maintains a policy
covering  product  liability  claims  for itself  and its  affiliates  with a $1
million per claim and $1 million annual  aggregate  limit and an umbrella policy
with a $40 million per claim and $40 million annual  aggregate  limit.  Although
the Company has not been the subject of material  product  liability  claims and
the laws and regulations  providing for such liability in the Company's  markets
appear to have been seldom utilized,  no assurance can be given that the Company
may not be exposed to future product liability  claims,  and, if any such claims
are  successful,  there can be no assurance  that the Company will be adequately
covered by  insurance  or have  sufficient  resources  to pay such  claims.  The
Company does not currently maintain its own product liability policy.

Competition

        The markets for  personal  care and  nutritional  products are large and
intensely  competitive.  The  Company  competes  directly  with  companies  that
manufacture  and market  personal care and  nutritional  products in each of the
Company's  product  lines.  The Company  competes  with other  companies  in the
personal care and  nutritional  products  industry by emphasizing  the value and
premium  quality of the Company's  products and the convenience of the Company's
distribution  system.  Many of the Company's  competitors have much greater name
recognition and financial resources than the Company. In addition, personal care
and  nutritional  products  can be  purchased  in a wide  variety of channels of
distribution.   While  the  Company  believes  that  consumers   appreciate  the
convenience  of ordering  products from home through a sales person or through a
catalog,  the buying habits of many consumers  accustomed to purchasing products
through  traditional  retail  channels are  difficult to change.  The  Company's
product offerings in each product category are also relatively small compared to
the wide variety of products offered by many other personal care and nutritional
product  companies.  There can be no assurance  that the Company's  business and
results of operations will not be affected  materially by market  conditions and
competition in the future.

        The Company also competes with other direct selling organizations,  some
of which have longer operating histories and higher visibility, name recognition
and financial resources.  The leading network marketing company in the Company's
existing markets is Amway  Corporation and its affiliates.  The Company competes
for new  distributors  on the  basis  of the  Global  Compensation  Plan and its
premium  quality  products.  Management  envisions the entry of many more direct
selling  organizations  into the  marketplace  as this  channel of  distribution
expands over the next several  years.  The Company has been advised that certain
large,   well-financed  corporations  are  planning  to  launch  direct  selling
enterprises which will compete with the Company in certain of its product lines.
There can be no assurance that the Company will be able to successfully meet the
challenges posed by this increased competition.

        The Company  competes  for the time,  attention  and  commitment  of its
independent  distributor force. Given that the pool of individuals interested in
the business  opportunities  presented by direct  selling tends to be limited in
each market,  the potential pool of distributors  for the Company's  products is
reduced to the extent other network  marketing  companies  successfully  recruit
these individuals into their businesses.  Although  management believes that the
Company  offers an attractive  business  opportunity,  there can be no assurance
that other network marketing






companies  will not be able to recruit the Company's  existing  distributors  or
deplete the pool of potential distributors in a given market.

Operations Outside the United States

        The Company's revenues and most of its expenses are recognized primarily
outside of the United  States.  Therefore,  the  Company is subject to  transfer
pricing  regulations and foreign exchange control,  taxation,  customs and other
laws.  The  Company's  operations  may be materially  and adversely  affected by
economic, political and social conditions in the countries in which it operates.
A change in policies by any government in the Company's  markets could adversely
affect the Company and its operations  through,  among other things,  changes in
laws,  rules  or  regulations,  or  the  interpretation  thereof,   confiscatory
taxation, restrictions on currency conversion, currency repatriation or imports,
or the expropriation of private enterprises. Although the general trend in these
countries has been toward more open markets and trade policies and the fostering
of private  business and economic  activity,  no assurance can be given that the
governments  in these  countries  will  continue to pursue such policies or that
such policies will not be significantly altered in future periods. This could be
especially  true in the event of a change  in  leadership,  social or  political
disruption  or  upheaval,  or  unforeseen   circumstances   affecting  economic,
political  or  social  conditions  or  policies.  The  Company  is aware of news
releases in South Korea, for example,  reporting  comments by political  figures
proposing  restrictions on foreign direct sellers designed to protect the market
share of local  companies.  There can be no assurance that such  activities,  or
other similar activities in the Company's markets, will not result in passage of
legislation or the enactment of policies which could materially adversely affect
the Company's operations in these markets. In addition, the Company's ability to
expand  its  operations  into  the new  markets  for  which it has  received  an
exclusive license to distribute NSI products will directly depend on its ability
to  secure  the  requisite  government  approvals  and  comply  with  the  local
government  regulations in each of those countries.  The Company has in the past
experienced  difficulties  in  obtaining  such  approvals as a result of certain
actions taken by its  distributors,  and no assurance can be given that these or
similar  problems  will not prevent the Company from  commencing  operations  in
those countries. See "--Entering New Markets."

Anti-Takeover Effects of Certain Charter, Contractual and Statutory Provisions

        The Board of Directors is authorized, subject to certain limitations, to
issue without  further consent of the  stockholders  up to 25,000,000  shares of
preferred stock with rights,  preferences and privileges designated by the Board
of Directors.  In addition,  the Company's Certificate of Incorporation requires
the  approval of 662/3% of the  outstanding  voting  power of the Class A Common
Stock and the Class B Common  Stock to authorize  or approve  certain  change of
control transactions.  See "Description of Capital  Stock--Common  Stock--Voting
Rights"  and  "--Mergers  and  Other  Business   Combinations."   The  Company's
Certificate of  Incorporation  and Bylaws also contain  certain  provisions that
limit the ability to call special  meetings of  stockholders  and the ability of
stockholders to bring business  before or to nominate  directors at a meeting of
stockholders.  See  "Description  of  Capital  Stock--Other  Charter  and  Bylaw
Provisions."  Pursuant to the 1996 Stock Incentive Plan, in the event of certain
change of control  transactions  the Board of  Directors  has the  right,  under
certain  circumstances,  to accelerate the vesting of options and the expiration
of any restriction periods on stock awards.  Finally,  the Operating  Agreements
with NSI and NSIMG are subject to  renegotiation  after December 31, 2001 upon a
change  of  control  of  the  Company.  Any  of  these  actions,  provisions  or
requirements could have the effect of delaying, deferring or preventing a change
of control of the Company. See "Recent Developments."

        The Company is subject to the  provisions  of Section 203 of the General
Corporation Law of the State of Delaware (the  "Anti-Takeover  Law")  regulating
corporate   takeovers.   The   Anti-Takeover   Law  prevents   certain  Delaware
corporations,  including those whose securities are listed on the New York Stock
Exchange,   from  engaging,   under  certain   circumstances,   in  a  "business
combination"  (which  includes  a merger of more  than 10% of the  corporations'
assets) with an  "interested  stockholder"  (a  stockholder  who,  together with
affiliates and associates, within the prior three years owned 15% or more of the
corporation's  outstanding voting stock) for three years following the date that
such  stockholder  became an  "interested  stockholder,"  unless  the  "business
combination" or "interested  stockholder" is approved in a prescribed  manner. A
Delaware corporation may "opt






out"  of the  Anti-Takeover  Law  with  an  express  provision  in its  original
certificate  of  incorporation  or an express  provision in its  certificate  of
incorporation or bylaws resulting from a stockholders'  amendment approved by at
least a majority of the  outstanding  voting shares.  The Company has not "opted
out" of the provisions of the Anti-Takeover Law.

Restrictions on Resale of Shares Underlying Distributor Options

        By  exercising  any  portion  of his or her  Distributor  Options,  each
distributor who has been granted more than 3,000 Distributor  Options will agree
not to resell in any given six-month period more than 33% of the shares of Class
A Common Stock  issuable upon exercise of the  Distributor  Options held by such
distributor. See "Plan of Distribution--Distributor Options."

Regulatory and Taxation Risks

        The availability of employee stock bonus awards in each country in which
NSI distributors  and/or employees reside is entirely dependent upon and subject
to NSI's ability to secure any necessary regulatory approvals, qualifications or
exemptions in each such country.  There can be no assurance  that such approvals
or qualifications will be secured or, once secured, will not be suspended. It is
possible that NSI may not be able to secure the necessary  regulatory  approvals
or  qualifications  in certain  countries.  The receipt of employee  stock bonus
awards will also  subject  the  recipient  to  potentially  material  income tax
implications. The Company and its affiliates anticipate that the shares of Class
A Common Stock  underlying  the employee stock bonus awards will be qualified in
some form  pursuant to the  securities  laws of each  jurisdiction  in which the
Company and its affiliates operate. There can be no assurance, however, that NSI
will be able to qualify the employee stock bonus awards in each  jurisdiction or
that, if qualified,  the governmental authorities in such jurisdictions will not
require  material  modifications  to the  terms  of the  programs  as  they  are
currently contemplated to be implemented. In addition, there can be no assurance
that  the  laws  and  relevant   regulations  and  judicial  and  administrative
interpretations  in such  jurisdictions  will not change in a manner  that has a
material impact on the ability of NSI to adopt or maintain such programs in such
jurisdictions.  The NSI  Distributor  Stock  Option  Plan,  as amended (the "NSI
Distributor  Stock Option Plan"),  as it is implemented or  administered  in any
given  country  where   distributors   of  NSI  reside  or  act  as  independent
distributors of NSI, may be amended or modified by NSI's board of directors from
time to time to comply  with the legal  requirements  and  restrictions  of such
country. See "Plan of Distribution --Regulatory and Tax Issues."

Absence of Dividends

        The Company does not  anticipate  that any dividends will be declared on
either  its Class A Common  Stock or its Class B Common  Stock in the  immediate
future.  The Company intends from time to time to re-evaluate  this policy based
on its net income and its alternative  uses for retained  earnings,  if any. Any
future  declaration  of dividends will be subject to the discretion of the board
of directors of the Company  (the "Board of  Directors")  and subject to certain
limitations  under the General  Corporation  Law of the State of  Delaware  (the
"DGCL").  The timing,  amount and form of dividends,  if any, will depend, among
other things, on the Company's results of operations,  financial condition, cash
requirements  and other factors deemed  relevant by the Board of Directors.  See
"--Reliance on Operations of and Dividends and Distributions from Subsidiaries."

Shares Eligible For Future Sale

        Future sales of  substantial  amounts of the Class A Common Stock in the
public market or the perception  that such sales could occur may have an adverse
effect on the market price of the Class A Common Stock. In addition,  any future
issuances of Class A Common Stock or other  capital  stock of the Company  could
also  be  dilutive  to  investors  in the  Class A  Common  Stock.  See  "Recent
Developments"  and  "Description  of  Capital  Stock--Preferred  Stock--The  NSI
Acquisition."  As of March 5, 1998,  11,835,737  shares of Class A Common  Stock
were  outstanding.  All of the  outstanding  shares of Class A Common  Stock are
freely tradeable without






restriction or further  registration  under the Securities  Act,  unless held by
"affiliates"  of the  Company,  as that  term  is  defined  in  Rule  144 of the
Securities Act ("Rule 144").  The shares of Class A Common Stock  underlying the
Distributor Options and the employee stock bonus awards to be issued pursuant to
the Rule 415 Offerings are subject to certain vesting and resale limitations.

        In  addition  to the  shares  to be  issued  pursuant  to the  Rule  415
Offerings, an aggregate of approximately 3,825,000 shares have been reserved for
issuance for future  option  grants and other equity  awards under the NSAP 1996
Stock Incentive  Plan. The Company  intends to file a registration  statement on
Form S-8 under  the  Securities  Act to  register  all of the  shares of Class A
Common Stock reserved for issuance under the NSAP 1996 Stock  Incentive Plan. In
addition,  the Company has reserved 250,825 shares of Class A Common Stock to be
issued upon the  exercise of a stock option  granted to an executive  officer of
the Company.

        As of March 5, 1998, the number of outstanding  shares of Class B Common
Stock was  70,280,759,  each share of which is  convertible at any time into one
share of Class A Common  Stock.  All  shares  of the  Class B Common  Stock  are
"restricted"  shares  within  the  meaning  of Rule 144 of the  Securities  Act.
Restricted  shares may not be resold in the public  market  except in compliance
with the  registration  requirements  of the  Securities  Act or  pursuant to an
exemption therefrom,  including the exemption provided by Rule 144. The Original
Stockholders  have  entered into a  stockholders  agreement  (the  "Stockholders
Agreement")  pursuant to which they  agreed not to transfer  any shares they own
through  November 28, 1998 (the "Initial Lock-up Period") without the consent of
the Company. However, if the NSI Acquisition is consummated,  the lock-up period
will  automatically be extended until one year following the closing date of the
NSI Acquisition (the "Extended Lock-up Period").  In addition,  the Stockholders
Agreement  further  restricts  the number of shares of Class A Common Stock that
may be sold by the Original Stockholders in a public resale pursuant to Rule 144
or any other exempt  transaction under the Securities Act for one year following
the last to expire of the Initial Lock-up Period or the Extended Lock-up Period.
The Original  Stockholders have been granted  registration rights by the Company
permitting each such Original Stockholder to register his or her shares of Class
A Common Stock, subject to certain restrictions,  on any registration  statement
filed by the Company until such Original  Stockholder has sold a specified value
of shares of Class A Common Stock.

                                 USE OF PROCEEDS

        Other  than the  exercise  price of such  Distributor  Options as may be
exercised,  the Company will not receive any proceeds from the  distribution  of
shares  of  Class A  Common  Stock  by the  Company  and the  Rule  415  Selling
Stockholders  in  connection  with the employee  stock bonus  awards.  The gross
proceeds  from the  issuance of shares of Class A Common Stock by the Company in
connection  with the  exercise of the  Distributor  Options are  estimated to be
approximately  $9.2 million (assuming the exercise of all 1,605,000  Distributor
Options).  Any  proceeds  received  by the  Company  will  be used  for  general
corporate  purposes,  which may include additional  capital expansion  projects.
Pending  such use,  the  Company  intends to invest  such  proceeds,  if any, in
short-term, interest bearing, investment grade instruments.

                          RULE 415 SELLING STOCKHOLDERS

        Prior  to  the  date  of  this  Prospectus,  the  Original  Stockholders
contributed an aggregate of 1,250,000  shares of Class A Common Stock to NSI and
its affiliates  (other than the Company) for use in connection with the employee
stock  bonus  awards to be made by the Rule 415  Selling  Stockholders  to their
respective  employees  pursuant to their  respective  stock  incentive  plans in
connection  with  the Rule  415  Offerings.  See  "Plan  of  Distribution."  The
following  table sets forth the name of each Rule 415  Selling  Stockholder  for
whom shares of






Class A Common  Stock  have  been  registered  pursuant  to Rule 415  under  the
Securities  Act,  the number of shares of Class A Common  Stock  owned and to be
offered in Rule 415 Offerings by each Rule 415 Selling Stockholder and the total
voting power of each Rule 415 Selling Stockholder after the Rule 415 Offerings.


Class A Common Stock -------------------------------------------------- Owned and To Be Offered in To Be Owned After the the Rule 415 Offerings(2) Rule 415 Offering -------------------------- --------------------- Rule 415 Selling Stockholders(1) Number Number % -------------------------------- ---------- -------- --- Nu Skin International, Inc. .............. 1,136,524 -- -- Nu Skin Personal Care Australia, Inc. .... 25,148 -- -- Nu Skin New Zealand, Inc. ................ 5,110 -- -- Nu Skin Mexico, Inc. ..................... 13,483 -- -- Nu Skin Guatemala, Inc. .................. 1,500 -- -- Nu Skin Canada, Inc. ..................... 33,775 -- -- Nu Skin Netherlands, Inc. ................ 3,398 -- -- Nu Skin U.K., Inc. ....................... 5,755 -- -- Nu Skin Germany, Inc. .................... 4,236 -- -- Nu Skin Belgium, Inc. .................... 3,400 -- -- Nu Skin France, Inc. ..................... 6,193 -- -- Nu Skin Italy, Inc. ...................... 4,157 -- -- Nu Skin Spain, Inc. ...................... 4,894 -- -- Nu Skin Puerto Rico, Inc. ................ 2,427 -- -- - ----------- (1) Each of the Rule 415 Selling Stockholders is an affiliate of the Company in that each Rule 415 Selling Stockholder is owned by the same individuals who owned approximately 98% of the voting control of the Common Stock as of the date of this Prospectus. See "Recent Developments." (2) Includes up to 1,250,000 shares of Class A Common Stock to be offered by the Rule 415 Selling Stockholders in connection with employee stock bonus awards.
In addition to the shares of Class A Common Stock being offered by the Rule 415 Selling Stockholders, the Company is offering up to 1,605,000 shares of Class A Common Stock to be issued upon the exercise of Distributor Options and up to 175,000 shares of Class A Common Stock as employee stock bonus awards to its employees. See "Plan of Distribution." PLAN OF DISTRIBUTION General This Prospectus may be used from time to time by the holders who offer the securities registered hereby pursuant to Rule 415 under the Securities Act for sale in transactions in which they are or may be deemed to be "underwriters" within the meaning of the Securities Act. The Class A Common Stock may be offered from time to time directly by the holders or pledgees, donees, transferees or other successors in interest. Alternatively, the Class A Common Stock may be offered from time to time by the holders or through brokers or dealers who may act solely as agents, or may acquire shares as principals. The distribution of the Class A Common Stock may be effected in one or more transactions that may take place on the New York Stock Exchange, including block trades, ordinary brokers' transactions, privately negotiated transactions or through sales to one or more broker/dealers for resale of such securities as principals, at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. Usual and customary or specifically negotiated brokerage fees or commissions may be paid by these holders in connection with such sales. In connection with such sales, the holders and any participating brokers or dealers may be deemed "underwriters" as such term is defined in the Securities Act. If required, a prospectus supplement will be distributed setting forth the names of any participating brokers or dealers, any applicable commissions or discounts and the net proceeds to the Rule 415 Selling Stockholders from such sale. The Rule 415 Selling Stockholders will bear all expenses (including underwriting discounts and selling commissions, state and local transfer taxes, and fees and expenses of counsel or other advisors to the Rule 415 Selling Stockholders) in connection with the registration of the offered securities. Distributor Options Prior to the date of this Prospectus, the Original Stockholders contributed to the Company 1,605,000 shares of the Company's Class A Common Stock for use in implementing the NSI Distributor Stock Option Plan. Also prior to the date of this Prospectus, the Company granted to NSI an option (the "Option") to acquire such 1,605,000 shares of Class A Common Stock, which NSI Option was divisible and assignable by NSI for purposes of granting Distributor Options pursuant to the NSI Distributor Stock Option Plan. Pursuant to the terms of the NSI Distributor Option Plan, NSI has granted 1,605,000 Distributor Options to eligible distributors who achieved and maintained certain sales volume levels ("Executive Pin Levels") during a qualifying period in 1997. Each Distributor Option entitles the holder to purchase one share of Class A Common Stock at an exercise price of $5.75 (the "Exercise Price"), which is 25% of the initial price per share to the public in the Company's initial public offering of Class A Common Stock. All of the 1,605,000 Distributor Options have vested and are exercisable by each distributor until December 31, 2001, provided that the distributor maintains an Executive Pin Level of "Gold" or higher under the terms of the NSI Distributor Stock Option Plan until the date of exercise. Because of local legal and other requirements, the NSI Distributor Stock Option Plan as implemented in the Netherlands and Hong Kong has been changed to provide that vested distributor options will be exercisable for 90 days following December 31,1997, provided a Netherlands or Hong Kong distributor holding such Distributor Options maintains an Executive Pin Level of Gold or higher until the date of exercise. No Distributor Options will be exercisable after December 31, 2001. By exercising any portion of the Distributor Options, each distributor granted more than 3,000 Distributor Options agrees not to resell in any given six-month period more than 33% of the shares of Class A Common Stock issuable upon exercise of the Distributor Options originally granted to such distributor. By receiving an allocation of Distributor Options, each distributor confirmed his or her agreement to continue to resell or personally consume at least 80% of all products purchased by such distributor per month. Product returns after January 1, 1998 will reduce commission levels and may affect distributor Executive Pin Levels, consequently impacting the number of Distributor Options received by a distributor. In the event of product returns occurring after January 1, 1998 which would have affected distributor Executive Pin Levels or qualification for or vesting of Distributor Options had such product returns been made during 1997, NSI reserves the right to use any actions or remedies available to it under the NSI distributor policies and procedures, as may be amended from time to time, to recoup the value of the Distributor Options received by an Eligible Distributor in excess of the value of Distributor Options which would have been received or vested had such product returns been made prior to January 1, 1998. Employee Stock Bonus Awards Prior to the date of this Prospectus, the Original Stockholders also contributed an aggregate of 1,250,000 shares of Class A Common Stock to NSI and its affiliates (other than the Company) for use in connection with the employee stock bonus awards to be made by NSI and its affiliates (other than the Company) to their respective employees in connection with the Rule 415 Offerings. The grant of stock bonus awards and the terms thereof will be governed by the respective stock incentive plans of NSI and its affiliates (other than the Company). The shares of Class A Common Stock underlying each such employee stock bonus award will be issued to the employee recipient at a rate of 25% per year commencing one year following the date of the award, unless otherwise specified, provided the employee recipient is still employed by NSI or one of its affiliates (other than the Company). As of March 5, 1998, NSI and its affiliates (other than the Company) had made stock bonus awards for 466,563 shares of Class A Common Stock, of which awards for 20,122 shares had lapsed in connection with the termination of the employee recipients. The Company will also issue up to 175,000 shares of Class A Common Stock in connection with stock bonus awards that may be made to its employees pursuant to the NSAP 1996 Stock Incentive Plan on terms substantially similar to those described above in relation to the employee stock bonus awards to be made by NSI and its affiliates (other than the Company). As of March 5, 1998, the Company has made stock bonus awards for 175,490 shares of Class A Common Stock, of which awards for 14,104 shares have lapsed in connection with the employment termination of certain recipients. Regulatory and Tax Issues Certain U.S. Tax Consequences to Recipients of Distributor Options and Employee Stock Bonus Awards. For purposes of the Internal Revenue Code of 1986 as amended (the "Code"), the Distributor Options will be considered non-qualified stock options. A recipient (an "Option Recipient") of a non-qualified stock option recognizes no taxable income when a non-qualified stock option is granted. Upon exercise of a non-qualified stock option, the Option Recipient recognizes ordinary income equal to the difference between the exercise price and the fair market value of the shares on the date of exercise. The Option Recipient recognizes as capital gain or loss any subsequent profit or loss recognized on the sale or exchange of any shares disposed of or sold. A recipient (an "Employee Stock Bonus Award Recipient") of restricted stock or contingent stock is not required to include the value of such shares in income until the first time such Employee Stock Bonus Award Recipient's rights in the shares are transferable or not subject to substantial risk of forfeiture, whichever occurs earlier. In the case of restricted stock or contingent stock, the amount of such ordinary income will be equal to the excess of the fair market value of the shares at the time the income is recognized over the amount (if any) paid for the shares. Recipients of Distributor Options and employee stock bonus awards should consult their own tax advisors regarding the U.S. tax consequences of being awarded a Distributor Option or an employee stock bonus award. In addition, non-U.S. recipients of Distributor Options and employee stock bonus awards should consult with their own tax advisors regarding the application of the tax laws of their respective countries to the Distributor Options and employee stock bonus awards. Non-U.S. Regulatory and Tax Considerations. The Company and its affiliates anticipate that the Distributor Options, the shares of Class A Common Stock underlying the Distributor Options and the employee stock bonus awards will be qualified in some form pursuant to the securities and regulatory laws of each jurisdiction in which the Company and its affiliates operate. There can be no assurance, however, that NSI will be able to qualify the Distributor Options and the employee stock bonus awards in each jurisdiction or that, if qualified, the governmental authorities in such jurisdictions will not suspend such qualifications or require material modifications to the terms of the programs as they are currently contemplated to be implemented. In certain countries, including Belgium, France, Spain and possibly others, only existing distributors and/or existing executive distributors will be allowed to participate in the NSI Stock Option Plan. In addition, there can be no assurance that the laws and relevant regulations and judicial and administrative interpretations in jurisdictions will not change in a manner that has a material impact on the ability of NSI to adopt or maintain such programs in such jurisdictions. The exercise of Distributor Options and the sale of the shares of Class A Common Stock underlying such Distributor Options, and receipt of employee stock bonus awards and the sale of the shares of Class A Common Stock underlying such stock bonus awards, will have certain material income tax implications for the distributors of NSI and the employees of the Company and NSI. Although this Prospectus and related documentation contains certain tax information relevant to distributors of NSI and employees of the Company and NSI and its affiliates (other than the Company), such information is only intended to be a summary of certain relevant provisions and does not address all aspects of tax law that may be relevant to each distributor and employee based on the individual circumstances of such distributor and employee in each jurisdiction in which they operate. Distributors and employees are urged to consult their own tax advisors with respect to the particular tax consequences to them of the exercise of the Distributor Options and the purchase, ownership and disposition of the Class A Common Stock, including the applicability of any federal, state, provincial or foreign tax laws to which they may be subject as well as with respect to the possible effects of changes in tax laws in each jurisdiction, including changes which may be applied retroactively in a manner that could adversely affect holders of the Class A Common Stock. DESCRIPTION OF CAPITAL STOCK General As of the date of this Prospectus, the authorized capital stock of the Company consists of 500,000,000 shares of Class A Common Stock, 100,000,000 shares of Class B Common Stock, and 25,000,000 shares of Preferred Stock. As of March 5, 1998, the Company had 11,835,737 shares of Class A Common Stock issued and outstanding and 70,280,759 shares of Class B Common Stock issued and outstanding, all of which are held of record by the Original Stockholders and certain of their affiliates. Of the authorized shares of Preferred Stock, no shares of Preferred Stock were outstanding as of March 5, 1998; however, if the NSI Acquisition is consummated, the Company will issue shares of Series A Preferred Stock as partial consideration for NSI Acquisition. See "Recent Developments" and "--Preferred Stock." The following description of the Company's capital stock is a summary and is subject to and qualified in its entirety by reference to the provisions of the Company's Amended and Restated Certificate of Incorporation (the "Certificate of Incorporation"). Common Stock The approximate number of holders of record of the Company's Class A Common Stock and Class B Common Stock as of March 5, 1998 was 895 and 63, respectively. The shares of Class A Common Stock and Class B Common Stock are identical in all respects, except for voting rights and certain conversion rights and transfer restrictions regarding the shares of the Class B Common Stock, as described below. Voting Rights. Each share of Class A Common Stock entitles the holder to one vote on each matter submitted to a vote of the Company's stockholders and each share of Class B Common Stock entitles the holder to ten votes on each such matter, including the election of directors. There is no cumulative voting. Except as required by applicable law, holders of Class A Common Stock and holders of Class B Common Stock will vote together on all matters submitted to a vote of the stockholders. With respect to certain corporate changes, such as liquidations, reorganizations, recapitalizations, mergers, consolidations and sales of substantially all of the Company's assets, holders of Class A Common Stock and holders of Class B Common Stock will vote together as a single class and the approval of 662/3% of the outstanding voting power is required to authorize or approve such transactions. See "Risk Factors--Control by Original Stockholders; Anti-Takeover Effect of Dual Classes of Common Stock" and "--Anti-Takeover Effects of Certain Charter, Contractual and Statutory Provisions." Any action that can be taken at a meeting of the stockholders may be taken by written consent in lieu of a meeting if the Company receives consents signed by stockholders having the minimum number of votes that would be necessary to approve the action at a meeting at which all shares entitled to vote on the matter were present. This could permit holders of Class B Common Stock to take all actions required to be taken by the stockholders without providing the other stockholders an opportunity to make nominations or raise other matters at a meeting. The right to take action by less than unanimous written consent expires at such time as there are no shares of Class B Common Stock outstanding. Dividends. Holders of Class A Common Stock and holders of Class B Common Stock are entitled to receive dividends at the same rate if, as and when such dividends are declared by the Board of Directors of the Company out of assets legally available therefor after payment of dividends required to be paid on shares of Preferred Stock, if any. If a dividend or distribution payable in Class A Common Stock is made on the Class A Common Stock, the Company must also make a pro rata and simultaneous dividend or distribution on the Class B Common Stock payable in shares of Class B Common Stock. Conversely, if a dividend or distribution payable in Class B Common Stock is made on the Class B Common Stock, the Company must also make a pro rata and simultaneous dividend or distribution on the Class A Common Stock payable in shares of Class A Common Stock. See "Risk Factors--Absence of Dividends." Restrictions on Transfer. If a holder of Class B Common Stock transfers such shares, whether by sale, assignment, gift, bequest, appointment or otherwise, to a person other than a permitted transferee (as defined in the Company's Certificate of Incorporation) such shares will be converted automatically into shares of Class A Common Stock. In the case of a pledge of shares of Class B Common Stock to a financial institution, such shares will not be deemed to be transferred unless and until a foreclosure occurs. Conversion. The Class A Common Stock has no conversion rights. The Class B Common Stock is convertible into shares of Class A Common Stock, in whole or in part, at any time and from time to time at the option of the holder, on the basis of one share of Class A Common Stock for each share of Class B Common Stock converted. In the event of a transfer of shares of Class B Common Stock to any person other than a "Permitted Transferee" (as defined in the Certificate of Incorporation) each share of Class B Common Stock so transferred automatically will be converted into one share of Class A Common Stock. Each share of Class B Common Stock will also automatically convert into one share of Class A Common Stock if, on the record date for any meeting of the stockholders, the number of shares of Class B Common Stock then outstanding is less than 10% of the aggregate number of shares of Class A Common Stock and Class B Common Stock then outstanding. Liquidation. In the event of liquidation, after payment of the debts and other liabilities of the Company and after making provision for the holders of Preferred Stock, if any, the remaining assets of the Company will be distributable ratably among holders of Class A Common Stock and holders of Class B Common Stock treated as a single class. Mergers and Other Business Combinations. Upon the merger or consolidation of the Company, holders of each class of Common Stock are entitled to receive equal per share payments or distributions, except that in any transaction in which shares of capital stock are distributed, such shares may differ as to voting rights to the extent and only to the extent that the voting rights of the Class A Common Stock and the Class B Common Stock (collectively, the "Common Stock") differ at that time. The Company may not dispose of all or any substantial part of the assets of the Company to, or merge or consolidate with, any person, entity or "group" (as defined in Rule 13d-5 of the Exchange Act), which beneficially owns in the aggregate 10% or more of the outstanding Common Stock and Common Stock of the Company (a "Related Person") without the affirmative vote of the holders, other than such Related Person, of not less that 662/3% of the voting power of outstanding Class A Common Stock and Class B Common Stock voting as a single class. For the sole purpose of determining the 662/3% vote, a Related Person will also include the seller or sellers from whom the Related Person acquired, during the preceding six months, at least 5% of the outstanding shares of Class A Common Stock in a single transaction or series of related transactions pursuant to one or more agreements or other arrangements (and not through a brokers' transaction), but only if such seller or sellers have beneficial ownership of shares of Common Stock having a fair market value in excess of $10 million in the aggregate following such disposition to such Related Person. This 662/3% voting requirement is not applicable, however, if (i) the proposed transaction is approved by a vote of not less than a majority of the directors of the Company who are neither affiliated nor associated with the Related Person (or the seller of shares to the Related Person as described above) or (ii) in the case of a transaction pursuant to which the holders of Common Stock are entitled to receive cash, property, securities or other consideration, the cash or fair market value of the property, securities or other consideration to be received per share in such transaction is not less than the higher of (A) the highest price per share paid by the Related Person for any of its holdings of Common Stock within the two-year period immediately prior to the announcement of the proposed transaction or (B) the highest closing sale price during the 30-day period immediately preceding such date or during the 30-day period immediately preceding the date on which the Related Person became a Related Person, whichever is higher. See "Risk Factors--Anti-Takeover Effects of Certain Charter, Contractual and Statutory Provisions." Other Provisions. Holders of the Class A Common Stock and holders of Class B Common Stock are not entitled to preemptive rights. Neither the Class A Common Stock nor the Class B Common Stock may be subdivided or combined in any manner unless the other class is subdivided or combined in the same proportion. Transfer Agent and Registrar. The Transfer Agent and Registrar for the Class A Common Stock is American Stock Transfer and Trust Company. Listing. The Class A Common Stock is traded on the New York Stock Exchange under the trading symbol "NUS." There is currently no public market for the Class B Common Stock. Preferred Stock General The Board of Directors is authorized, subject to any limitations prescribed by the DGCL or the rules of the New York Stock Exchange or other organizations on whose systems stock of the Company may be quoted or listed, to provide for the issuance of additional shares of Preferred Stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the rights, powers, preferences and privileges of the shares of each wholly unissued series and any qualifications, limitations or restrictions thereon, and to increase or decrease the number of shares of such series, without any further vote or action by the stockholders. The approval of the holders of at least 662/3% of the combined voting power of the outstanding shares of Common Stock, however, is required for the issuance of shares of Preferred Stock that have the right to vote for the election of directors under ordinary circumstances or to elect 50% or more of the directors under any circumstances. Depending upon the terms of the Preferred Stock established by the Company's Board of Directors, any or all series of Preferred Stock could have preference over the Common Stock with respect to dividends and other distributions and upon liquidation of the Company or could have voting or conversion rights that could adversely affect the holders of the outstanding Common Stock. In addition, the Preferred Stock could delay, defer or prevent a change of control of the Company. See "Risk Factors--Anti-Takeover Effects of Certain Charter, Contractual and Statutory Provisions." The NSI Acquisition If the NSI Acquisition is consummated, the Company will issue shares of Series A Preferred Stock as partial consideration for the NSI Acquisition. Pursuant to the Acquisition Agreement, the number of shares of Series A Preferred Stock to be issued will be determined by dividing $70 million by the average closing price of the Class A Common Stock reported on the New York Stock Exchange for the 20 consecutive trading days ending five trading days prior to the closing of the NSI Acquisition. To comply with certain rules and regulations of the New York Stock Exchange, if the NSI Acquisition is consummated, the Certificate of Designation setting forth the terms of the Series A Preferred Stock will provide that the Series A Preferred Stock cannot be converted into Class A Common Stock until the holders of the Common Stock approve the issuance of Class A Common Stock upon conversion of the Series A Preferred Stock or the requirements of the New York Stock Exchange are otherwise satisfied to permit conversion thereof. The Company intends to submit a proposal to the holders of Common Stock in connection with the Company's 1998 annual meeting of stockholders requesting the holders of Common Stock to approve the issuance of shares of Class A Common Stock upon conversion of the Series A Preferred Stock (the "Proposal"). If the NSI Acquisition is consummated and shares of Series A Preferred Stock are issued, the Company anticipates that the Series A Preferred Stock will have the following rights, powers, preferences and privileges. Dividends. Prior to September 30, 1998, the holders of the Series A Preferred Stock will share equally in any dividends declared, paid or set apart for payment on the Common Stock or any other class or series of stock of the Company ranking, as to dividends, on a parity with or junior to the Series A Preferred Stock. At any time after September 30, 1998, if the holders of Common Stock do not approve the Proposal and the requirements of the New York Stock Exchange are not otherwise satisfied to permit conversion of the Series A Preferred Stock to Class A Common Stock on or before such date, the holders of the Series A Preferred Stock will be entitled to cash dividends after that date at the rate of 7% of the "Preference Value" per share of Series A Preferred Stock per annum (the "Cumulative Dividends"). The "Preference Value" will be equal to 60% of the average closing price of the Class A Common Stock reported on the New York Stock Exchange for the 20 consecutive trading days ending five trading days prior to the closing of the NSI Acquisition. The Cumulative Dividends must be paid in full before any dividends can be paid on securities ranking junior to the Series A Preferred Stock (including the Common Stock). The Cumulative Dividends will be payable in quarterly installments on each March 31, June 30, September 30 and December 31, commencing December 31, 1998. The Cumulative Dividends will accrue (whether or not declared) from September 30, 1998 and accrued Cumulative Dividends will accumulate to the extent not paid in a quarterly dividend period. Liquidation Preference. The Series A Preferred Stock will have a liquidation preference equal to the Preference Value. Upon the liquidation, dissolution or winding up of the Company, holders of the Series A Preferred Stock will be entitled to the Preference Value per share of the Series A Preferred Stock plus any accrued and unpaid dividends on the Series A Preferred Stock (collectively, the "Series A Liquidation Preference") prior to any payment being made to holders of the Common Stock or any stock of the Company junior to the Series A Preferred Stock. In the event there are sufficient assets to pay the full Series A Liquidation Preference, any remaining assets will first be distributed to the holders of the Common Stock in a total amount equal to the Series A Liquidation Preference and will thereafter be distributed to the holders of the Common Stock and the holders of the Series A Preferred Stock pro rata based on the number of shares held by each holder. The sale of all or substantially all of the assets of the Company or the consolidation or merger of the Company with another entity will be deemed to be a liquidation, dissolution or winding up of the Company for purposes of the Series A Liquidation Preference. Optional Redemption by the Company. The Series A Preferred Stock will be redeemable by the Company at its option in whole, but not in part, at any time after September 30, 1998, if the stockholders do not approve the Proposal or the requirements of the New York Stock Exchange are not otherwise satisfied to permit conversion of the Series A Preferred Stock to Class A Common Stock on or before such date. If these redemption provisions were triggered, the redemption price per share would be equal to the lesser of (i) the Preference Value or (ii) 60% of average of the last sales prices per share of the Class A Common Stock of the Company on the New York Stock Exchange for the 20 consecutive trading days ending on the trading day which is five trading days prior to the redemption date. The redemption price would be payable 25% in cash on the redemption date and the remaining 75% in promissory notes. The principal on the promissory notes would be payable in three equal annual installments on the anniversary of the redemption date in each of the next three succeeding years, with interest on the unpaid principal balance payable at a rate per annum equal to the short term applicable federal rate as defined in the Code. Voting Rights. Holders of Series A Preferred Stock generally will have no voting rights. However, a vote or consent of 662/3% of the outstanding Series A Preferred Stock will be required for the Company to issue any class or series of stock ranking prior to or on a parity with the Series A Preferred Stock with respect to dividends or distribution of assets upon liquidation or for the Company to amend its Certificate of Incorporation so as to materially and adversely affect the rights and preferences of the Series A Preferred Stock. In addition, holders of Series A Preferred Stock will have the right to elect two new members of the Board of Directors if the right to receive Cumulative Dividends has been triggered and such Cumulative Dividends are in arrears in an amount equal to or greater than six quarterly Cumulative Dividends. Automatic Conversion. If the Proposal is approved by the holders of Common Stock, the outstanding shares of Series A Preferred Stock will be automatically converted into Class A Common Stock at the Conversion Ratio (as defined in the Certificate of Designation) then in effect. The Conversion Ratio initially will be one share of Class A Common Stock per share of Series A Preferred Stock, and will be subject to adjustment for dilutive issuances of securities. Right to Redeem the Class A Common Stock Issuable Upon Conversion of Series A Preferred Stock. If the holders of Common Stock approve the Proposal, pursuant to the NSI Acquisition Agreement the Company will have the right to redeem the Class A Common Stock issued upon conversion of the Series A Preferred Stock. Subject to the limitations described below, the redemption price per share will initially be the average closing price of the Class A Common Stock reported on the New York Stock Exchange for the 20 consecutive trading days ending five trading days prior to the closing of the NSI Acquisition, and will increase on each anniversary date of the issuance of the Class A Common Stock as follows: Date Redemption Price ---- ---------------- Issuance 100% First Anniversary 120% Second Anniversary 140% Third Anniversary 160% Fourth Anniversary 180% Fifth Anniversary 200% The redemption right expires on the sixth anniversary of the issuance of the Class A Common Stock upon conversion of the Series A Preferred Stock. In order for the redemption right to be exercised, the redemption price must be no more than 100% of the average of the last sales prices per share of the Class A Common Stock of the Company on the New York Stock Exchange for the 20 consecutive trading days ending on the trading date that is five trading days prior to the date of the redemption. In addition, in order for such redemption right to be exercised, at least two-thirds of the independent members of the Board of Directors must approve the redemption after consideration of relevant alternate cash investments available to the Company at that time. Other Charter and Bylaw Provisions Special meetings of stockholders may be called only by the majority stockholders, the Board of Directors or the President or Secretary of the Company. Except as otherwise required by law, stockholders, in their capacity as such, are not entitled to request or call a special meeting of the stockholders. Stockholders of the Company are required to provide advance notice of nominations of directors to be made at, and of business proposed to be brought before, a meeting of the stockholders. The failure to deliver proper notice within the periods specified in the Company's Amended and Restated Bylaws (the "Bylaws") will result in the denial of the stockholder of the right to make such nominations or propose such action at the meeting. See "Risk Factors--Anti-Takeover Effects of Certain Charter, Contractual and Statutory Provisions." Section 203 of the Delaware General Corporation Law The Company is a Delaware corporation and is subject to the provisions of Section 203 of the DGCL (the "Anti-Takeover Law") regulating corporate takeovers. The Anti-Takeover Law prevents certain Delaware corporations, including those whose securities are listed on the New York Stock Exchange, from engaging, under certain circumstances, in a "business combination" with an "interested stockholder" (a stockholder who, together with affiliates and associates, within the prior three years did own 15% or more of the corporation's outstanding voting stock) for three years following the date that such stockholder became an "interested stockholder," unless the "business combination" or "interested stockholder" is approved in a prescribed manner. A Delaware corporation may "opt out" of the Anti-Takeover Law with an express provision in its original certificate of incorporation or an express provision in its certificate of incorporation or bylaws resulting from a stockholders' amendment approved by at least a majority of the outstanding voting shares. The Company has not "opted out" of the provisions of the Anti-Takeover Law. See "Risk Factors--Anti-Takeover Effects of Certain Charter, Contractual and Statutory Provisions." Indemnification and Limitation of Liability of Directors and Officers To the fullest extent permitted by the DGCL, the Company's Certificate of Incorporation and Bylaws provide that the Company shall indemnify and advance expenses to each of its directors, officers, employees and agents. The Company believes the foregoing provisions are necessary to attract and retain qualified persons as directors and officers. The Company has entered into separate indemnification agreements with each of its directors and executive officers in order to effectuate such provisions. The Company's Certificate of Incorporation also provides for, to the fullest extent permitted by the DGCL, elimination or limitation of liability of directors for breach of their fiduciary duty to the Company or its stockholders. Registration Rights Under the Stockholders' Agreement, the Original Stockholders have been granted registration rights by the Company permitting each of such Original Stockholders to register his or her shares of Class A Common Stock, subject to certain restrictions, on any registration statement filed by the Company until such Original Stockholder has sold a specified value of shares of Class A Common Stock. CERTAIN UNITED STATES TAX CONSEQUENCES TO NON-UNITED STATES HOLDERS The following is a general discussion of certain United States federal income and estate tax consequences of the ownership and disposition of Class A Common Stock by a Non-U.S. Holder. For this purpose, a "Non-U.S. Holder" is any person who is, for United States federal income tax purposes, a foreign corporation, a non-resident alien individual, a foreign partnership or a foreign estate or any trust unless a court within the United States is able to exercise primary supervision over the administration of the trust and one or more United States persons has the authority to control all substantial decisions over the trust. This discussion does not address all material aspects of United States federal income and estate taxes and does not deal with foreign, state and local consequences that may be relevant to such Non-U.S. Holders in light of their personal circumstances. Furthermore, this discussion is based on provisions of the Code, existing and proposed regulations promulgated thereunder and administrative and judicial interpretations thereof, as of the date hereof, all of which are subject to change (possibly with retroactive effect). Each prospective purchaser of Class A Common Stock is advised to consult a tax advisor with respect to current and possible future tax consequences of acquiring, holding and disposing of Class A Common Stock as well as any tax consequences that may arise under the laws of any foreign or U.S. state, municipality or other taxing jurisdiction. An individual may, subject to certain exceptions, be deemed to be a resident alien (as opposed to a non-resident alien) by virtue of being present in the United States for 183 days or more during the calendar year or on at least 31 days in the calendar year and for an aggregate of at least 183 days during a three-year period ending in the current calendar year (counting for such purposes all of the days present in the current year, one-third of the days present in the immediately preceding year, and one-sixth of the days present in the second preceding year). Resident aliens are subject to U.S. federal tax as if they were U.S. citizens. Dividends Dividends paid to a Non-U.S. Holder of Class A Common Stock generally will be subject to withholding of United States federal income tax either at a rate of 30% of the gross amount of the dividends or at such lower rate as may be specified by an applicable income tax treaty. However, dividends that are effectively connected with the conduct of a trade or business by the Non-U.S. Holder within the United States and, where a tax treaty applies, are attributable to a United States permanent establishment of the Non-U.S. Holder, are not subject to the withholding tax (provided the Non-U.S. Holder files appropriate documentation, including, under current law, IRS Form 4224, with the payor of the dividend), but instead are subject to United States federal income tax on a net income basis at applicable graduated individual or corporate rates. Any such effectively connected dividends received by a foreign corporation may, under certain circumstances, be subject to an additional "branch profits tax" at a 30% rate or such lower rate as may be specified by an applicable income tax treaty. Under United States Treasury regulations that apply to dividends paid before January 1, 1999, dividends paid to an address outside the United States are presumed to be paid to a resident of such country (unless the payer has knowledge to the contrary) for purposes of the withholding discussed above and for purposes of determining the applicability of a tax treaty rate. Under United States Treasury regulations that apply to dividends paid after December 31, 1998, a Non-U.S. Holder of Class A Common Stock wishing to claim the benefit of an applicable treaty rate will be required to satisfy applicable certification and other requirements either directly or through an intermediary. In addition, backup withholding, as discussed below, may apply in certain circumstances if applicable certification and other requirements are not met. Gain on Disposition of Common Stock A Non-U.S. Holder will generally not be subject to United States federal income tax with respect to gain recognized on a sale or other disposition of Class A Common Stock unless (i) the gain is effectively connected with a trade or business of the Non-U.S. Holder in the United States, and, where a tax treaty applies, is attributable to a United States permanent establishment of the Non-U.S. Holder, (ii) in the case of a Non-U.S. Holder who is an individual and holds the Class A Common Stock as a capital asset, such holder is present in the United States for 183 or more days in the taxable year of the sale or other disposition and certain other conditions are met, or (iii) the Company is or has been a "U.S. real property holding corporation" for United States federal income tax purposes. The Company believes it is not and does not anticipate becoming a "U.S. real property holding corporation" for United States federal income tax purposes. If an individual Non-U.S. Holder falls under clause (i) above, he will, unless an applicable treaty provides otherwise, be taxed on his net gain derived from the sale under regular graduated United States federal income tax rates. If an individual Non-U.S. Holder falls under clause (ii) above, he will be subject to a flat 30% tax on the gain derived from the sale, which may be offset by certain United States capital losses. If a Non-U.S. Holder that is a foreign corporation falls under clause (i) above, it will be taxed on its gain under regular graduated United States federal income tax rates and may be subject to an additional branch profits tax at a 30% rate, unless it qualifies for a lower rate under an applicable income tax treaty. Federal Estate Tax Class A Common Stock held by an individual Non-U.S. Holder at the time of death will be included in such holder's gross estate for United States federal estate tax purposes, unless an applicable estate tax treaty provides otherwise. Information Reporting and Backup Withholding Tax The Company must report annually to the IRS and to each Non-U.S. Holder the amount of dividends paid to such holder and the tax withheld with respect to such dividends, regardless of whether withholding was required. Copies of the information returns reporting such dividends and withholding may also be made available to the tax authorities in the country in which the Non-U.S. Holder resides under the provisions of an applicable income tax treaty. A backup withholding tax is imposed at the rate of 31% on certain payments to persons that fail to furnish certain identifying information to the payor under the United States information reporting requirements. Under United States Treasury regulations that apply to dividends paid before January 1, 1999, backup withholding generally will not apply to dividends paid to a Non-U.S. Holder at an address outside the United States (unless the payer has knowledge that the payee is a U.S. person), but generally will apply to dividends paid on Class A Common Stock at addresses inside the United States to Non-U.S. Holders that fail to provide certain identifying information in the manner required. Under Treasury regulations that apply to dividends paid after December 31, 1998, a Non-U.S. Holder generally would be subject to backup withholding at a 31% rate, unless certain certification procedures (or, in the case of payments made outside the United States with respect to an offshore account, certain documentary evidence procedures) are complied with, directly or through an intermediary or a Non-U.S. Holder otherwise establishes an exemption from backup withholding. Payment of the proceeds of a sale of Class A Common Stock by or through a United States office of a broker is subject to both backup withholding and information reporting unless the beneficial owner provides the payor with its name and address and certifies under penalties of perjury that it is a Non-U.S. Holder, or otherwise establishes an exemption. In general, backup withholding and information reporting will not apply to a payment of the proceeds of a sale of Class A Common Stock by or through a foreign office of a foreign broker. If, however, such broker is, for United States federal income tax purposes a U.S. person, a controlled foreign corporation, or a foreign person that derives 50% or more of its gross income for certain periods from the conduct of a trade or business in the United States, such payments will be subject to information reporting, but not backup withholding, unless (i) such broker has documentary evidence in its records that the beneficial owner is a Non-U.S. Holder and certain other conditions are met, or (ii) the beneficial owner otherwise establishes an exemption. Any amounts withheld under the backup withholding rules generally will be allowed as a refund or a credit against such holder's U.S. federal income tax liability provided the required information is furnished in a timely manner to the IRS. LEGAL MATTERS The validity of the issuance of the shares of Class A Common Stock offered hereby will be passed upon for the Company and the Rule 415 Selling Stockholders by LeBoeuf, Lamb, Greene & MacRae, L.L.P., a limited liability partnership including professional corporations, Salt Lake City, Utah. EXPERTS The consolidated financial statements incorporated in this Prospectus by reference to the Nu Skin Asia Pacific, Inc. Annual Report on Form 10-K for the year ended December 31, 1997 have been so incorporated in reliance on the report of Price Waterhouse LLP, independent accountants, given on authority of said firm as experts in auditing and accounting. - ------------------------------------ ------------------------------------ No person is authorized to give any information or make any representations other than those contained in this Prospectus and, if given or made, such information or representations must not be relied 3,030,000 Shares upon as having been authorized by the Company, any Rule 415 Selling Stockholder or any other person. This Prospectus does not constitute an offer to sell or a solicitation of any offer to purchase any securities other than those to which [LOGO] it relates or an offer to sell or a solicitation of an offer to purchase any securities in any jurisdiction where such an offer or solicitation would be unlawful. Neither the delivery of this Prospectus nor any distribution of securities hereunder shall under any circumstances be deemed to imply that there has been Class A Common Stock no change in the assets, properties or affairs of the Company since the date hereof or that the information set forth herein is correct as of any time subsequent to the date hereof. ------------------ ------------------- PROSPECTUS ------------------ TABLE OF CONTENTS Page ---- Available Information..............2 Incorporation by Reference.........2 Forward-Looking Statements.........3 The Company........................4 Recent Developments................5 Risk Factors.......................8 Use of Proceeds...................23 Rule 415 Selling Stockholders.....23 Plan of Distribution..............24 Description of Capital Stock......27 Certain United States Tax Consequences to Non-United March 20, 1998 States Holders...................32 Legal Matters.....................34 Experts...........................34 - ------------------------------------ ------------------------------------